Benzo Recovery Coaching

"I'm not going to
tell you there's
nothing you can do."

For those injured by benzos, most resources tell you to wait. For some people that works. For others, waiting is not neutral — it may allow a progressive process to continue unchecked. Interventions exist.
Everything I've learned is here, free. None of it is certain. All of it is worth knowing.

30M+
Americans on benzos annually
~2M
Estimated Americans with BIND
Benzodiazepine-Induced Neurological Dysfunction [est. 10–25% of long-term users]
40 Years
From first documented BIND cases to a formal name for the condition
$4B+
Annual global pharma revenue from benzodiazepines [source]
$0
Federal research dollars allocated to BIND treatment

The information you needed.
That nobody gave you.

Prescribed for sleep — one month. Didn’t help much. Told to taper off in two weeks. Gaslit when the injury appeared — worsened for six months.

The real reason this site exists: if someone had found me at that moment — before I became bed-ridden in a dark basement with my nightmares — and said here is a framework, here are some interventions, here is what others have found — everything might have been different. That information is here now. Freely. No opt-in required.

The coaching is for people experiencing neurological symptoms from benzodiazepines — whether still tapering, recently off, or years out. BIND often starts during the taper, not after. [PLOS ONE 2025] If you’re in it at any stage and want help figuring out what to try first, in what order, and why — that’s what this is for.

A note on certainty: BIND recovery is still being figured out in real time — by researchers, by clinicians, and by the people living it. This is a space for intelligent, humble experimentation. Not a protocol handed down from authority. We’re all in this together.

Justin Michelson

Author · Meditation teacher · Pacific Northwest

  • ⚗️
    Active, Not PassiveOne specific intervention per session. One clear thing to try. No more white-knuckling it alone.
  • 🆓
    Everything Free FirstThe full list of what worked, what didn't, and why — published free, no opt-in required
  • 🧘
    Science + SpiritMechanistic depth alongside meditation, nature, and the wisdom traditions that hold what neuroscience can't
  • ⚖️
    Radically AccessibleSliding scale. Full scholarships available. No one is ever turned away.

Sessions opening Fall 2026

One email when the door opens. No newsletter, no marketing.

The work.
The philosophy.

Recovery from benzo injury isn't passive. It's an active, intelligent, deeply personal process — and you deserve a guide who's lived it.

Why this work exists

When you're in the depths of BIND — the pain, the hypersensitivity, the neurological chaos — the standard medical response is often "wait and see." You're handed nothing. No roadmap, no interventions, no acknowledgment that what you're experiencing is even real.

That's not good enough. We understand the mechanisms — GABAergic disruption, NMDA upregulation, neuroinflammation, autonomic dysregulation. And where there are mechanisms, there are potential interventions.

Everything I've learned is freely available on the What Works page. The coaching is for people at any stage — still tapering, recently off, or years out. BIND frequently begins during the taper itself. The coaching is for anyone experiencing neurological symptoms from benzodiazepines who wants help structuring their recovery.

"I’ve been to hell and back. And love is still at the center of everything. I can confirm it."— From the blog

What this coaching is — and isn't

This is not medical advice. I'm a recovery coach and lived-experience guide, not a physician. I work alongside your providers, not instead of them.

This is not passive support. You'll leave every session with one specific thing to try. That's the whole point.

This is not hand-holding. Short sessions, text access, rapid iteration. You experiment, report back, we refine. It respects your intelligence and autonomy.

This is not only clinical. Nature, mindfulness, and the spiritual dimension of healing are woven through this work — not as substitutes for interventions, but as essential partners.

And honestly — this isn't my main gig. I'm a meditation teacher and I run a native plant nursery. I'm not building a coaching empire. I just remember what it felt like to be in the worst of BIND with nobody willing to engage, and I want to help a few people who are in that situation. That's the whole reason this exists.

🧠

Mechanistic First

Understanding what's happening in your nervous system creates agency. Mystery breeds fear; knowledge creates a foundation for action.

🌲

Nature as Medicine

Decades of research support nature exposure as a regulator of the autonomic nervous system. This isn't metaphor — it's biology.

🔬

Active Experimentation

You are the expert on your own body. The goal is equipping you with well-reasoned options to test, track, and refine.

☸️

Buddhist Foundations

Impermanence, non-attachment, present-moment awareness — these aren't just philosophy in BIND recovery. They're survival tools.

⚖️

Radical Accessibility

BIND often costs people everything. The information is free. The coaching is sliding scale. Full scholarships exist.

🤝

Lived Experience

I've navigated a complex BIND presentation firsthand. That's not just credibility — it's the reason this exists.

The three structural dilemmas
of BIND recovery.

These aren't just challenges. They're logical traps that make BIND uniquely difficult to navigate without someone who understands them — and almost nobody in conventional medicine does.

1

The Energy Paradox

Healing requires energy. Cellular repair, neuroplasticity, tissue regeneration — all of it is metabolically expensive. But in BIND, your inhibitory system is broken. Any significant activation — a brisk walk, an exciting conversation, even a supplement that nudges the wrong pathway — can tip your nervous system past its regulatory threshold and cost you the night's sleep.

And without sleep, nothing heals. So you're caught: you need activation to heal, but activation prevents the sleep that makes healing possible.

The way out isn't doing more or doing less — it's finding the precise activation threshold your nervous system can tolerate right now, which changes constantly and is different for every person. That threshold is what we're always calibrating.

2

The Unpredictability Problem

In a healthy nervous system, responses are roughly proportional to inputs. In BIND, that relationship breaks down. Something that was fine yesterday destroys you today. Something that triggered you for months suddenly stops causing problems. There's no reliable map, and no amount of careful tracking fully predicts what comes next.

This is why BIND is so hard to explain to family, friends, and doctors. You can't run in the morning not because you're deconditioned or afraid, but because your nervous system has lost its ability to respond proportionally to physical stress. The problem isn't in your head — it's in your inhibitory circuitry.

Every intervention is an experiment with an n of 1. The goal isn't to find the perfect protocol — it's to build a practice of intelligent experimentation and learn to read your own signals more accurately over time.

3

The Tolerance & Rotation Problem

You find something that works. Real relief — better sleep, less pain, calmer nervous system. You feel hopeful for the first time in months. And then, after weeks or sometimes just days, it stops working. The effect fades. Sometimes it reverses. This isn't a sign that you've failed or that recovery isn't real — it's a fundamental feature of a sensitized nervous system adapting to repeated inputs.

GABA receptors downregulate under sustained activation. Mast cells sensitize to repeated triggers. Sodium channels adapt. The nervous system in BIND is in a state of hyperreactive plasticity — it changes fast, in both directions.

Pulsing and rotating interventions isn't optional — it's the only sustainable model. This means cycling supplements, varying practices, taking breaks from things that are working before they stop. Almost nobody talks about this. It's one of the most practically important things to understand about long-term BIND recovery.

"These three dilemmas are why a standard treatment protocol doesn't exist for BIND — and why one-size-fits-all advice from people who haven't lived it tends to make things worse. Navigating them requires constant recalibration, a high tolerance for uncertainty, and someone who actually understands the terrain."

My Story

Why I do this work, and what I bring to it. — Justin Michelson

Justin Michelson

Author of The Dharma of Healing · Meditation teacher · Native plant nursery owner · Pacific Northwest

I had no intention to become someone who helps the pharmaceutically-injured. I became one the only way most people do — by living with it, in a body that stopped working the way it was supposed to, in a medical system that had no map for what was happening to me.

Before everything changed

I’ve always been someone oriented toward nature and meaning. I’m a meditation teacher. I run a native plant nursery in the Pacific Northwest, which is as close to a spiritual practice as anything I’ve ever done.

I tell you this not as credentials but as context. I wasn’t someone who stumbled into contemplative practice after getting sick. It was already the center of my life. And when everything fell apart, it was one of the only things that held.

The Injury

What happened

I was prescribed lorazepam — Ativan — for severe insomnia following a complicated heat exhaustion injury. One month, prescribed doses, legitimate medical reason.

It got me a few hours of sleep each night, but my anxiety started getting worse. By the end of that month I was having interdose withdrawal during the day — agitated, angsty, something wrong in a way I couldn’t name. Then I stopped taking it for a day. A huge withdrawal surge came on. I almost went to the hospital. I didn’t know what was happening to me.

I restarted and called my doctor. He said taper off in two weeks. I started. It got super hellish, nightmarish. I called him again. He said stay on it then. I said I didn’t think I could — it was so terrible even while I was on it. So I tapered in a little over two weeks, down to 1/8mg.

That’s when the hypersensitivity appeared.

I found a new psychiatrist. He transitioned me to Valium and told me to taper off that last bit over six weeks. I did. It didn’t help. The injury was already there. It didn’t go away.

I want to be clear about this timeline because it matters: one month of use. Two-week taper. The injury started before the taper was even finished — possibly before it began. Years of consequences. That’s not an edge case. That’s a predictable outcome of a prescribing and discontinuation practice that happens millions of times a year in this country.

The withdrawal and its aftermath were unlike anything I had a framework for. Trigeminal pain that made light and sound feel like violence to the center of my soul. Autonomic surges that revved up all night long, leaving me lifeless and charged with electricity for days. A hypersensitivity to vibration and pressure that made even bending over an impossible task. A nervous system that couldn’t tell the difference between threat and safety, rest and activation, pain and neutral sensation. Grotesque intrusive thoughts of a kind I had never had before in my life.

And beneath all of it, the exhaustion and terror.

Things continued to get worse for five months after my last benzo — and didn’t start improving until I began actively treating it. The “waves and windows” pattern that gets talked about in recovery communities has never been my experience. It was just worse, then slowly better once I found the right interventions. This is one of the things nobody warns you about: stopping isn’t the bottom. For some people the bottom comes later.

I went to doctors. I described what was happening as clearly as I could. Most of them looked at my labs — which were largely normal — and reflected my symptoms back to me as anxiety, as depression, as something psychological that would benefit from therapy or another medication. A few were kind. Almost none had any idea what BIND was, or that it had a name, or that millions of people were living in exactly this state.

The Education

Learning what was actually happening

Out of necessity, I became a student. I read everything I could find — the research that existed, the patient accounts, the emerging clinical literature. I started to understand the mechanisms: what benzodiazepine use had likely done to my GABA receptors [PMC], how NMDA receptor upregulation worked [PNAS 2012], what neuroinflammation looked like in a sensitized nervous system, why the autonomic dysregulation was so pervasive and so hard to explain to people who hadn’t felt it.

Understanding what was happening didn’t fix it. But it changed my relationship to it. Mystery breeds fear. Knowing the mechanism — even when the mechanism is complicated and the prognosis is uncertain — creates a foundation for action. It gave me something to work with instead of just something to endure.

At the same time, I leaned harder into the practices I already had. Buddhist meditation — specifically working with impermanence, with the reality that this moment, however terrible, is not permanent — became genuinely therapeutic rather than just philosophical. Time in nature, which had always mattered to me, turned out to have real biological effects on a dysregulated autonomic nervous system. These weren’t soft alternatives to the clinical work. They were doing something the clinical interventions couldn’t — addressing the nervous system’s relationship to its own experience.

Still Here

Where I am now

I’m still in recovery. I want to be honest about that. This site is going live before I’m fully healed — because the information is needed now and the recovery is mine regardless. I’m posting what I know because I can’t justify sitting on it while people are suffering in the dark.

What I’ve found is that recovery is real. It is genuinely happening. The nervous system, for all its apparent fragility in BIND, is also capable of remarkable reorganization given the right conditions and enough time. I’ve found interventions that moved the needle and learned — the hard way, in some cases — what didn’t work and why.

The coaching I’m hoping to offer for Fall 2026 is what I wish I’d had when I was in the worst of it. Not someone to sit with me in the suffering — I had meditation for that. Someone who actually understood the mechanisms and could help me think clearly about what to try, in what order, and why. Someone who’d been deep enough in it to know that the standard advice is insufficient, and to offer something better, to take risks with me.

I’m a meditation teacher and I run a native plant nursery. This isn’t my main gig and I’m not building a coaching empire. I want to help a few people who are in a situation I understand from the inside. That’s the whole reason this exists.

The BIND
Framework

Five phenotypes. Five treatment pillars. How they map to each other — and what it means for your recovery.

The five phenotypes described here are based on Dr. Valsa Madhava's 2025 research framework (medRxiv preprint: "Benzodiazepine Withdrawal Symptom Clusters: Distinct Phenotypes with Treatment Implications"). The five treatment pillars reflect a clinical framework developed through lived experience and independent research. Neither constitutes medical advice. This is educational material to support informed conversations with your providers.

Who this is for: This framework applies whether you are still tapering, recently off, or years out. BIND doesn't always begin after discontinuation — it often starts during the taper itself. My own injury began during the first two weeks, while I was still on benzos. If you are experiencing neurological symptoms from benzodiazepines at any stage — still on, tapering, or post-taper — this framework was written for you.

BIND — Benzodiazepine-Induced Neurological Dysfunction — is the term for neurological injury that persists after benzodiazepine use, beyond the acute withdrawal period. Named by the Benzodiazepine Nosology Workgroup in 2023.

BIND is not one disorder.
It's at least five.

The single biggest reason BIND is so hard to treat is that it gets approached as a unitary syndrome — one set of symptoms, one recovery trajectory, one approach. But the research and clinical experience both show clearly that people with BIND cluster into distinct biological phenotypes with different dominant mechanisms, different symptom profiles, and different optimal treatment approaches.

Knowing your phenotype changes what you try first. It changes what you prioritize. It changes what you stop doing that isn't moving the needle. This is the framework that underlies every recommendation made in coaching sessions.

The Five Phenotypes
Based on Madhava (2025)

35.9% of patients

CRH-Adrenergic

The dominant driver here is the stress axis — specifically dysregulation of corticotropin-releasing hormone (CRH) and the adrenergic system. The HPA axis has been destabilized by chronic GABAergic suppression and is now hyperreactive. These patients wake with cortisol surges, experience adrenergic storms, have heightened startle responses, and feel wired and exhausted simultaneously.

Hallmark symptoms: Morning cortisol spikes, absent awakening response, adrenaline rushes, terror upon waking, hypervigilance, temperature dysregulation, disproportionate stress responses, inability to downregulate after activation.

33.3% of patients

Excitatory–Neuroinflammatory (ENI)

The dominant driver is the excitatory/inhibitory imbalance — NMDA receptor upregulation combined with neuroinflammatory activation. Without sufficient GABAergic inhibition, glutamate tone rises unchecked, driving excitotoxic neuroinflammation. These patients have the most intense sensory symptoms and often the most severe cognitive involvement.

Hallmark symptoms: Extreme light/sound sensitivity, tinnitus, burning sensations, trigeminal activation, brain fog, cognitive dysfunction, head pressure, intrusive thoughts, chemical sensitivities — driven by neuroinflammatory cascades and excitotoxic pressure.

10.3% of patients

Autonomic

The dominant driver is autonomic nervous system dysregulation — loss of appropriate sympathetic/parasympathetic balance. The nervous system has lost its ability to modulate heart rate, blood pressure, temperature, and digestion appropriately. These patients experience pronounced cardiovascular symptoms and orthostatic issues.

Hallmark symptoms: Palpitations, POTS-like orthostatic intolerance, blood pressure swings, temperature dysregulation, GI motility issues, diaphoresis, syncope or near-syncope, exercise intolerance disproportionate to deconditioning.

Rare in cohort

Basal Ganglia–Cerebellar (BG/Cer)

Dominant involvement of motor control and sensory gating circuits — the basal ganglia and cerebellum are heavily GABA-dependent and show significant dysfunction when GABAergic tone is disrupted. These patients present with prominent movement, coordination, and sensory gating symptoms that are often misdiagnosed as neurological disease.

Hallmark symptoms: Tremor, myoclonus, coordination difficulties, gait disturbance, inner vibration, akathisia-like restlessness, sensory gating failure (unable to filter background noise/stimulation), motor tics.

~53.8% — modifier

MCAS-Overlap

This isn't a standalone phenotype — it's a modifier that sits on top of any of the four above and amplifies symptom complexity significantly. Mast cell activation syndrome overlaps with BIND through shared neuroinflammatory mechanisms: mast cells release histamine, tryptase, and cytokines that directly activate NMDA receptors and drive neuroinflammation.

Hallmark symptoms: Flushing, hives, chemical/food sensitivities, GI reactions, new allergies, reactivity to heat/cold/pressure, symptoms that vary dramatically day to day without obvious cause. Present in over half of all BIND patients — if you have it, neuroinflammation becomes co-primary regardless of your base phenotype.

The Five Treatment Pillars

🔵

1 — GABAergic Stabilization

Supporting and restoring GABAergic tone without creating new dependence. Targets the core deficit driving BIND — insufficient inhibitory signaling. Approaches range from dietary support to targeted supplementation to lifestyle practices that upregulate endogenous GABA production.

🔴

2 — NMDA Reduction

Reducing glutamate/NMDA receptor hyperactivity — the other side of the E/I imbalance. When GABA drops, glutamate rises unchecked. NMDA antagonism, glutamate-reducing interventions, and dietary approaches that lower excitatory load all target this pillar.

🟠

3 — Neuroinflammation

Addressing the inflammatory cascade that both drives and results from E/I imbalance. Microglial activation, cytokine release, mast cell involvement, and blood-brain barrier disruption all feed this pillar. Anti-inflammatory interventions, mast cell stabilization, and gut-brain axis support are central.

🟢

4 — Neurotrophic Repair

Supporting the brain's ability to repair and reorganize — neuroplasticity, BDNF/NGF signaling, synaptic remodeling. This pillar is most active after the acute phase has stabilized. Peptides, exercise within tolerance, nature exposure, and certain supplements all support neurotrophic signaling.

🟣

5 — Autonomic Stabilization

Restoring the balance between sympathetic and parasympathetic tone. Vagal nerve support, HRV training, breathwork, temperature regulation, and interventions that reduce adrenergic hyperreactivity. Often the pillar that produces the most immediate quality-of-life improvement when addressed directly.

The Matrix: Phenotype × Pillar

Every phenotype involves all five pillars — but the weighting differs dramatically. This matrix shows where to focus first based on your dominant phenotype. Primary = start here, hit hardest. Secondary = important, layer in early. Supportive = maintain but don't lead with.

Phenotype 🔵 GABAergic 🔴 NMDA 🟠 Neuro-inflammation 🟢 Neurotrophic 🟣 Autonomic
CRH-Adrenergic Primary Secondary Secondary Supportive Primary
ENI Secondary Primary Primary Secondary Supportive
Autonomic Secondary Supportive Secondary Supportive Primary
BG/Cerebellar Primary Secondary Supportive Primary Secondary
+ MCAS Modifier Secondary Secondary ↑ Co-Primary Supportive Secondary

Key insight: Most people with BIND are mixed phenotype to some degree — but there's usually a dominant cluster. Identifying which mechanisms are running loudest in your presentation is what allows you to sequence interventions intelligently rather than trying everything at once and not knowing what's doing what. The MCAS modifier, when present, elevates neuroinflammation to co-primary regardless of your base phenotype — which is why mast cell stabilization is often the first move in complex cases even when it doesn't seem like the central issue.

Are you getting better, worse, or neither — when you do nothing?

This single question carries more diagnostic weight than most people realize. Your spontaneous trajectory — independent of any interventions — tells you something fundamental about the biological state of your nervous system right now.

Slowly getting better

Your nervous system has enough baseline regulatory capacity to be healing on its own trajectory. Interventions can accelerate this — but the risk of disrupting the process is real. Start slow, go gentle, prioritize not disrupting what's already working. Your window of tolerance is probably wider than it feels.

Essentially neutral / plateaued

The system has stabilized but isn't moving. This is the most common presentation after the first 6–12 months. Active intervention is usually needed to break the plateau — but the fact that you're stable means you can tolerate more than someone who's actively worsening. This is typically the best time to start layering targeted interventions.

Slowly getting worse

Active neuroinflammatory or autonomic processes are outpacing the nervous system's ability to compensate. This changes the intervention priority significantly — stabilization before optimization. The goal is to stop the slide before trying to climb. MCAS-overlap should be ruled in or out immediately. More intensive support — including working with a physician — is warranted.

The Four-Stage Protocol

This is the methodology applied to every intervention recommended in coaching — regardless of what the intervention is. It respects the sensitized nervous system's need for graduated introduction, accounts for tolerance development, and gives you a clear decision tree for when to hold, when to increase, and when to rotate out.

1
Stage

Tolerance Test

A single low dose — once — taken in the morning. Morning is intentional: you want the full day to observe the response while awake, and if there's any stimulating or sleep-disrupting effect you'll find out that night rather than at 3am. Then 24–48 hours of observation before proceeding. In BIND, paradoxical and hypersensitive reactions are common, and an intervention that looks promising can cause a significant setback if introduced without testing first.

Exception: interventions specifically intended for sleep support — mirtazapine, glycine, certain sedating herbs — are tested at night by design. The follow-up email will specify timing when this applies.

Watching for: Sleep disruption that night or the following night, symptom flare, paradoxical stimulation, mast cell reaction (flushing, itching, GI). If any of these — stop, note it, report back. That's useful information. If neutral or positive — proceed to Stage 2.

2
Stage

Daily Establishment

Take the test dose daily for at least one week without increasing. The goal here is to establish a consistent baseline response — to distinguish a real effect from noise. BIND nervous systems are variable enough that a single day's response means very little.

Watching for: Is there a consistent, reproducible effect? Or is it random? If consistent and positive — move to Stage 3. If consistent and neutral — report back, may not be the right intervention for your phenotype. If inconsistent — hold at Stage 2 for another week before deciding.

3
Stage

Titration

Increase by one third every few days — not doubling, not jumping. One third is the increment because the sensitized nervous system needs time to adapt without tipping into reactivity. Continue until you reach optimal effect, or the first sign of diminishing returns or side effects.

Finding your window: When you hit a dose where the effect starts to flatten or side effects appear — back off one step. That's your therapeutic window. Stay there. This is the most important number to identify — it's personal to you and unlikely to match any standard recommendation.

4
Stage

Pulse & Rotate

When the effect plateaus or fades — and it will — this doesn't mean the intervention failed. It means the nervous system has adapted. Don't abandon it. Shift to pulsing: 5 days on, 2 off, or every other day, or whatever pattern preserves some effect without driving full tolerance. When pulsing itself stops working, rotate the intervention out temporarily.

Tolerance plateau vs healing plateau — an important distinction: Not all plateaus mean tolerance. A tolerance plateau is when the effect genuinely fades — you feel no better than before the intervention, or the benefit has reversed. A healing plateau is when the intervention is still working but the nervous system has reached its current ceiling of repair. You still feel meaningfully better than pre-intervention baseline; you just aren't continuing to improve. Hold the healing plateau for 2–4 weeks before deciding to pulse or rotate. The intervention may still be doing significant work below the symptom surface — BDNF upregulation, mitochondrial repair, receptor remodeling — that doesn't show up as continued subjective improvement. Only rotate out when you're returning toward pre-intervention baseline.

The rotation window: After 4–6 weeks off an intervention, it often works again — sometimes better than the first time. This is why maintaining a protocol log matters. Nothing is ever truly abandoned, just rested. The long-term goal is a rotation stack of several effective interventions that cycle in and out without any single one losing effect permanently.

Why this protocol exists: Most BIND supplement advice ignores tolerance development entirely — people are told to "take X daily" with no guidance on what happens when it stops working. The four stages treat the sensitized nervous system as what it actually is: a hyperreactive, highly adaptive system that responds well to gradual introduction and poorly to abrupt changes or sustained monotony. Every intervention recommended in coaching comes with a specific Stage 1 starting dose and a Stage 3 titration schedule in the follow-up email.

Hyper-adaptability: the double-edged sword

The rotation requirement isn't just an inconvenience to manage. Understanding why it exists reframes the entire BIND experience — and changes how you relate to your own nervous system.

The problem side

Benzodiazepine use and withdrawal leave the nervous system in a state of pathological plasticity — receptor remodeling in overdrive, synaptic scaling hyperactive, homeostatic mechanisms running constantly. This is what drives symptoms. And it's why interventions that work brilliantly in week one can be doing almost nothing by week four.

The nervous system isn't being stubborn. It's adapting — fast, relentlessly, to every input it receives. That's exhausting and frustrating. It's also something else.

The opportunity side

The same hyperplasticity that drives rapid tolerance development also means the nervous system is actively, urgently seeking equilibrium. A system that adapts this quickly to interventions can also adapt quickly toward health when given the right inputs in the right sequence.

People with BIND often notice effects from interventions at doses far below standard recommendations — not because they're unusually sensitive in a broken way, but because their nervous system is actively listening. The therapeutic window is narrow, but it's real and responsive.

What this means practically

Interventions work faster. A healthy nervous system requires sustained, significant input to produce measurable receptor changes. A BIND nervous system responds to small, targeted inputs within days. The flip side of that sensitivity is genuine responsiveness.

Low doses are therapeutic doses. Starting low isn't just a safety measure — it's often the optimal dose. Standard recommendations are built for normal nervous systems. The BIND therapeutic window is frequently a third to a half of what a healthy person would need.

The rotation stack builds over time. Each intervention you cycle through — even ones that plateau quickly — contributes to receptor remodeling and nervous system reorganization. The cumulative effect of intelligent rotation is greater than any single sustained intervention.

Tolerance fading means the nervous system moved. When an intervention stops working, the receptor state it was targeting has often shifted — which is the goal. The system reorganized. That's not failure. That's evidence of change.

The core observations on this page — that things stop working, that you have to rotate, that the nervous system is simultaneously hypersensitive and capable of rapid change — didn't come from research papers first. They came from years of accounts from people living with BIND, documented in communities like BenzoBuddies and r/benzorecovery long before clinical researchers caught up. The Ashton Manual itself was built largely from patient reports. Madhava's phenotype research surveyed people with lived experience. The frameworks here attempt to put mechanistic language around what the BIND community already knew.

"Your nervous system isn't fighting you. It's adapting to everything — including, eventually, the right inputs in the right sequence. The hyper-adaptability that makes this so hard to navigate is the same property that makes recovery genuinely possible."

Want help identifying your phenotype?

The intake form includes a symptom mapping section that helps identify your dominant phenotype before the first session. We then use the matrix to sequence your interventions — starting with the pillars most relevant to your specific presentation.

What I've Tried

Eighteen months of intensive personal experimentation, organized by mechanism. Not everything — probably about half of what I've actually tried. But the things most worth knowing about. Understanding the five pillars helps make sense of how this is organized.

This is one person’s experience.
Not a protocol. Not a prescription. Not advice.

BIND presentations vary enormously. What moved the needle for me may do nothing for you. Everything here is offered as a starting point for your own informed research. Always work with qualified providers before starting anything new.

Organized by the five treatment pillars

Each pillar addresses a distinct mechanism driving BIND. Within each pillar: standouts first, then partial benefit, then things that were theoretically sound but didn’t move the needle much, then setbacks. After the five pillars: sleep as its own section, and other medications worth knowing about.

Some interventions appear in multiple pillars because they work through more than one mechanism — iboga, ketamine, and LDN are all examples.

Pillar 1

GABAergic Floor Restoration

Rebuilding the inhibitory foundation destroyed by benzo withdrawal. [PNAS 2012] Without this floor, all other pillars are undermined.

Amanita Muscaria (Muscimol)

Standout

The only non-addictive GABA-A agonist in existence. Every other compound that directly agonizes GABA-A — benzos, barbiturates, alcohol, z-drugs — produces dependence. Muscimol doesn’t. For a BIND nervous system starving for inhibitory tone, this is uniquely valuable. Produced genuine calming for me, possibly improved sleep architecture, and reduced autonomic reactivity.

Preparation is critical: must be fully decarboxylated before use. Decarbing converts ibotenic acid (rough, potentially neurotoxic) to muscimol (the active compound you want). Improperly prepared amanita is a different and worse experience. Fully decarbed product is available from reputable vendors — don't guess on this step. Start at 100mg tolerance test, morning. Titrate up by one third. Well-tolerated at appropriate doses when correctly prepared.

Stresam (Etifoxine)

Partially Helpful

European anxiolytic with a dual mechanism: GABA-A modulation at a different site than benzos, plus endogenous neurosteroid synthesis — promoting the body’s own production of allopregnanolone. Non-addictive. The neurosteroid angle is particularly interesting mechanistically — rather than substituting for GABAergic activity, it may help restore the body’s own capacity to generate it.

Not FDA approved. Available in France, Germany, and other EU countries. Not a benzodiazepine — different mechanism, non-addictive.

Mulungu (Erythrina mulungu)

Partially Helpful

An obscure Brazilian rainforest plant with documented GABAergic activity — erythrinic alkaloids that interact with GABA-A receptors through a mechanism distinct from benzodiazepines, which makes it non-addictive and non-cross-tolerant. [J. Natural Products 2007] Research also shows inhibition of NMDA-evoked seizures, suggesting dual GABAergic and glutamatergic activity — though I can't speak to that from experience, only from the literature. Helpful for a period in my recovery; like most GABAergic compounds tolerance develops and it needs rotation.

Preparation matters: simmer the bark with lemon juice to extract the active alkaloids. The acid helps pull erythravine into the tea. Available as bark from ethnobotanical suppliers — not widely sold as a supplement.

Brew as tea: simmer bark with lemon juice 20–30 minutes. Start with a small test dose. Rotate with other GABAergic agents — tolerance develops with regular use.

Also tried — theoretically sound, limited benefit:

  • Progesterone (Progest-E) — converts to allopregnanolone, a GABA-A positive modulator. Real mechanism, limited benefit in practice for me at the doses I tried. Worth exploring, particularly for anyone with hormonal contributors to their BIND presentation.
  • Taurine — GABA-mimetic, glycine receptor agonist. Limited noticeable effect despite consistent use.
  • L-Theanine — mild GABA modulation. Gentle but effects are subtle.
  • Lemon Balm — GABA transaminase inhibitor. Low risk, low reward standalone.
  • Depakote (Valproate) — GABA transaminase inhibitor + sodium channel blocker + HDAC inhibitor (BDNF). Compelling mechanisms. Didn’t produce compelling results for me. Requires monitoring.
  • Tiagabine — GABA reuptake inhibitor (GAT-1 blocker). Keeps endogenous GABA in the synapse longer — a different mechanism from everything else. Interesting in theory, limited effect in practice for me.

Setback:

Flumazenil — benzodiazepine receptor antagonist sometimes discussed as a BIND treatment. Set me back significantly. The theoretical rationale exists but real-world response is highly variable. Approach with serious caution.

Pillar 2

NMDA Overdrive Reduction

Chronic NMDA overactivation drives excitotoxicity, maintains locus coeruleus sensitization, and regenerates neuroinflammation. [Psychiatric Services 2019] Reducing this is often the missing piece that allows everything else to work more completely.

IV Ketamine

Standout

A powerful reset tool for breaking cycles of neurological activation. NMDA antagonism directly addresses glutamate excitotoxicity, and at sub-anesthetic doses produces meaningful acute relief of sensitization states. Also in the neurotrophic pillar — ketamine triggers a rapid BDNF surge via TrkB [PubMed 2019] [Frontiers 2022], which is a separate and significant mechanism. Used therapeutically and as a rescue intervention during severe flares.

Requires clinical setting. Low-dose protocols (~30mg) are gentler than anesthetic doses. Integration support recommended.

Lithium Orotate

Worked Well

Meaningful calming, sensitivity reduction, and mood stabilization for me. Neuroprotective through multiple mechanisms: BDNF support, GSK-3β inhibition, NMDA modulation at low dose, and mitochondrial stabilization. The effect was substantially more noticeable at higher doses than the low amounts commonly recommended online — though this may vary by person. Not the same as prescription lithium carbonate and does not carry the same toxicity risk at these doses.

Start low and titrate up to 300–400mg orotate daily. Monitor for any signs of toxicity at higher doses. Not equivalent to prescription lithium — dose is not interchangeable.

Magnesium Glycinate

Partially Helpful

Magnesium is the endogenous NMDA channel blocker — it literally sits in the NMDA receptor channel at rest, providing natural protection against excitotoxic overactivation. [J. Neurosci. 2004] Deficiency appears common in BIND. Also supports GABA-A co-factor activity and sleep architecture. One of the highest-value, lowest-cost interventions in this space.

Start low and titrate up — loose stools are the natural ceiling. Glycinate form specifically. RBC magnesium testing recommended over serum. Note: magnesium L-threonate crosses the BBB more effectively and is worth trying for cognitive symptoms specifically, but the ceiling before GI effects is lower — you can’t get as high a dose.

Memantine

Partial / Unclear

Direct uncompetitive NMDA channel blocker — the most mechanistically precise intervention for excitotoxicity. Lessened nighttime activation in my experience, though the effect was subtle. Mechanistically it’s the right intervention and may require a longer trial and more established foundation before the full effect becomes clear.

5mg week 1, then 10mg. Prescription required. Immediate release preferred to start. Never stop abruptly — taper slowly when discontinuing.

Also tried:

  • Agmatine — indirect NMDA modulation via NOS inhibition, alpha-2 agonism, BDNF upregulation. Active in my current protocol at low dose. Subtle effects but mechanistically interesting across multiple pillars.

Pillar 3

Neuroinflammation & Mast Cell Control

Neuroinflammation and NMDA excitotoxicity are mutually reinforcing. Mast cell reactivity amplifies both. MCAS modifier is present in over half of BIND cases — for those people, mast cell stabilization is often a prerequisite for other interventions to work.

IV Glutathione

Standout

Like a fire extinguisher — a genuine “ahhh” effect. Anxiety lessened noticeably, sleep improved, that background neurological noise quieted. One of the more immediately felt interventions. IV delivery bypasses gut absorption limitations and the effect is distinct from oral or liposomal forms.

Note: can trigger a hepatic mobilization reaction — the liver releases stored toxins and the load can cause early-morning disruption and temporary worsening. Support detox pathways with TUDCA and phosphatidylcholine.

Requires clinical setting. Start low. Nebulized glutathione is a gentler option for ongoing use.

KPV (Lys-Pro-Val)

Standout

Alpha-MSH peptide. Direct NF-κB suppression, microglial modulation, mast cell stabilization, and mucosal repair. Particularly useful for the MCAS modifier component — reducing histamine and cytokine release that amplifies neuroinflammation. More impactful than a typical supportive adjunct for me, particularly during periods of clear mast cell activation.

Intranasal for CNS/airway targets; oral for gut. Part of an anti-inflammatory stack.

Low Dose Naltrexone (LDN)

Worked Well

At low doses, brief opioid receptor blockade triggers endorphin rebound upregulation. More relevantly for BIND: TLR4 antagonism on microglia directly reduces microglial activation and neuroinflammatory cascade. [PMC 2014] Growing evidence base for neuroinflammatory, autoimmune, and chronic pain conditions. [PMC 2014] Helpful for me over time, though effect took months to become apparent.

Prescription required. Typically compounded — start at 1.5mg, titrate up to 4.5mg. Take at bedtime. Allow 2–3 months for full effect.

Steroids (Nuanced)

Partial / Caution

Real anti-inflammatory and mast cell stabilization effects. Flonase (OTC fluticasone) was genuinely helpful. Dexamethasone and ophthalmic steroid drops produced meaningful relief of sensitization symptoms. For anyone who can tolerate steroids without sleep disruption, they’re a potentially significant intervention worth discussing with a provider.

The problem: steroids are stimulating and can significantly disrupt sleep. An interesting hypothesis: pairing with a GABAergic like amanita might offset the sleep cost while preserving the anti-inflammatory benefit.

Flonase is OTC and a low-risk starting point. Systemic steroids require a prescription. Sleep monitoring essential.

Ozone Therapy

Useful

Oxidative preconditioning via Nrf2/HO-1 anti-inflammatory rebound. May support mitochondrial function. Used carefully given sensitization, and helpful for me in moderate doses. Rectal insufflation is the primary delivery method. Critical rule: never consecutive days — the Nrf2 pathway needs a recovery interval. Stratus 3.0 generator in current use.

Single conservative dose. Never two consecutive days.

Also tried — mast cell & antihistamine support:

  • Fish Oil (high-dose EPA/DHA) — prostaglandin pathway anti-inflammatory, neuronal membrane integrity. Use triglyceride form at meaningful doses.
  • Astaxanthin — BBB-penetrant mitochondrial antioxidant. Takes weeks to accumulate to therapeutic levels.
  • Quercetin — mast cell stabilizer, NF-κB inhibitor. Phytosomal form for better bioavailability.
  • Ketotifen — antihistamine + mast cell stabilizer. OTC as eye drops; compounded oral via pharmacy.
  • H1 + H2 blockers combined — cetirizine/loratadine + famotidine covers more histamine territory than either alone.
  • Cromolyn Sodium — mast cell stabilizer, useful for gut mast cell activation. Prescription.
  • Low-histamine diet — temporary 2–4 week trial can meaningfully lower overall mast cell burden.

Setbacks:

Sulforaphane — potent Nrf2 activator with strong theoretical case. Set me back significantly. The mobilization and detox load exceeded my system’s clearance capacity, causing a major flare. Real mechanism — wrong timing for me. Not an early-recovery intervention.

Pillar 4

Neurotrophic Repair & BDNF

Rebuilding damaged neurons, synapses, and BBB infrastructure. Neurotrophic interventions work better as the excitotoxic and inflammatory environment is reduced by pillars 2 and 3.

Iboga (Total Alkaloid Extract)

Best Overall

The single most impactful intervention in my recovery. Sigma-1 receptor modulation, GDNF upregulation (the largest known GDNF surge of any intervention) [J. Neurosci. 2005] [Frontiers 2019], and neuroplasticity mechanisms unusually well-matched to BIND pathology. Total alkaloid extract is significantly smoother than HCl salt — less stimulating, more tolerable for a sensitized nervous system.

Critical: ibogaine is a potent CYP2D6 and CYP3A4 inhibitor. This affects metabolism of other substances and persists for days. When combining with amanita muscaria, reduce amanita to one quarter of your normal dose. Cardiac history must be reviewed before starting.

This is microdosing — not flood dose, not for getting off benzos. Start at 10mg and titrate up slowly. TAE preferred over HCl — significantly less activating, which matters for a sensitized nervous system. Paired particularly well with lithium orotate — the combination felt synergistic for nervous system stabilization. CYP inhibition is clinically significant and persists for days. CYP2D6 genotype matters.

TB-500 (Thymosin Beta-4)

Standout

BBB repair, vascular regeneration, tissue repair, anti-inflammatory, neurological recovery support across multiple systems. One of the more consistently reliable interventions in my stack with good tolerability for me. Works well alternating with BPC-157 in my experience.

2.5mg SubQ. 4 days on / 3 days off, alternated with BPC-157. Source quality critical — Eternal Peptides preferred.

Cerebrolysin

Promising

Neurotrophic peptide mixture with BDNF/NGF-like effects. Neuroprotective, may support cognitive recovery and neuroplasticity. One of the more serious neurotrophic tools available theoretically — still building my own experience with it. Can be purchased online without compounding — quality varies, source carefully.

IM injection. Start 2–3mg, build to 10mg. Start every 3 days to assess tolerance before increasing frequency. No compounding required — available from reputable peptide suppliers.

Exosomes

Partially Helpful

Extracellular vesicles from mesenchymal stem cells containing neurotrophic signals, growth factors, and anti-inflammatory microRNAs. Theoretically promising for CNS repair. Some benefit in my experience — not as dramatic as hoped, possibly reflecting timing, dosing, or source quality. Wharton’s Jelly-derived specifically preferred.

IV administration. Provider and product quality vary significantly in this unregulated space. Cost is substantial. Due diligence on provider credentials essential.

Stem Cell Therapy

Exploratory

MSC therapy with potential for cellular regeneration, immune modulation, and sustained neurotrophic signaling. The mechanistic case is compelling. Still experimental for neurological applications — being evaluated as a next step given partial benefit from exosomes.

Not a first-line intervention. Significant quality variation between providers. Some predatory operators in this space. Look for providers with documented protocols and outcome tracking.

Also tried — limited benefit for me:

  • BPC-157 — gut mucosal repair, tight junction restoration, vascular healing, gut-brain axis support. Strong theoretical case for BIND. Didn't produce noticeable results in my experience. May be more useful for people with prominent GI involvement.
  • GHK-Cu — gene modulation, tissue repair, neuroinflammation reduction, BDNF/NGF upregulation. Intranasal delivery for CNS targets. Didn't produce noticeable results in my experience. Well-documented mechanisms — may suit other presentations.
  • NAC (N-Acetyl Cysteine) — glutathione precursor, mucolytic, Nrf2 activator, glutamate modulator. Solid theoretical stack addition. Limited noticeable effect for me at standard doses. Possibly more relevant for mold or heavy metal presentations.

Setback:

7,8-DHF (7,8-Dihydroxyflavone) — a TrkB receptor agonist that directly mimics BDNF signaling without requiring BDNF itself. Compelling mechanism for BIND recovery — activating the neurotrophic pathway at the receptor level. Set me back significantly. The downstream effects of TrkB activation may be too stimulating for a sensitized BIND nervous system, particularly early in recovery. Worth knowing about but approach with caution and test carefully.

Pillar 5

Autonomic Stabilization

The sympathetic nervous system encodes and maintains all other pathology. All somatic and mind-body practices work through this pillar — they are autonomic regulation tools, not soft alternatives to it.

Sleep

See Below

Sleep is the most important variable in BIND recovery and deserves its own section. The rotation stack — mirtazapine, clonidine, gabapentin, antihistamines — is covered in detail below. All sleep interventions work through the autonomic nervous system. Restoring sleep is the highest-priority autonomic intervention there is.

Nature Immersion

Worked Well

Not a metaphor. Phytoncides, negative ions, reduced cortisol, reduced amygdala reactivity — the autonomic nervous system responds measurably to natural environments. [PMC 2023] [PMC 2025] Even 15–20 minutes can shift the window of tolerance. Zero cost, zero risk, zero tolerance development.

Vipassana / Mindfulness Meditation

Foundational

Working directly with the experience of suffering — not to escape it, but to change the relationship to it. Buddhist practice around impermanence is genuinely therapeutic in BIND. Fear and catastrophizing amplify symptoms enormously and keep the nervous system in fight-or-flight. This isn’t a soft alternative — it’s one of the highest-leverage autonomic regulation tools available. And it’s free.

Visualization — Your Future Healed Self

Worked Well

Imagining your future healed self pulling you through the present moment. Not as a cognitive exercise — feel it in your body. Where does health live in your body right now, even a small amount? What does it feel like to be that person, a year from now, no longer in this? Let that future version of you reach back. This is not wishful thinking. The nervous system responds to vividly imagined futures. Recruiting hope as a physiological signal is real autonomic medicine.

Stellate Ganglion Block (SGB)

Standout

One of the most direct interventions available for autonomic-predominant BIND. The stellate ganglion is a sympathetic nerve cluster in the neck — blocking it temporarily resets sympathetic tone and brings the nervous system down a notch in a way that’s difficult to achieve through other means. Multiple blocks brought meaningful relief each time. Originally developed for PTSD — a randomized trial showed significant symptom reduction vs sham. [JAMA 2020] Direct application to BIND dysautonomia.

Requires pain specialist or anesthesiologist. Ultrasound-guided, increasingly available. Search “stellate ganglion block” + your city.

Cold Immersion & Cold Shower

Worked Well

Cold water exposure activates the diving reflex and can produce a meaningful parasympathetic override. [Physiology 2017] Cold pack to the neck (carotid sinus + trigeminal activation) is the most effective acute tool for a surge in progress — use at onset, not after the surge is established, and intensity matters. Slow cold immersion (not shock exposure) builds parasympathetic tone progressively.

Cold pack to neck: use at onset of autonomic surge, not after. Intensity needed for full diving reflex.

Slow Diaphragmatic Breathing

Useful

~5–6 breaths per minute directly engages the parasympathetic nervous system and can measurably improve heart rate variability. Also addresses the trigeminal-autonomic loop by activating vagal tone. Zero cost, immediate effect, no tolerance development.

Kloud Mat (PEMF)

Supportive

PEMF mat with adjustable frequency settings. Still exploring this one — some relaxation benefit, possibly some sleep improvement, still figuring out the parameters. Go slow with intensity — more is not better in BIND.

Start at lowest settings. Still discovering optimal use.

Pharmacological autonomic support:

Clonidine — alpha-2 agonist suppressing locus coeruleus norepinephrine output. Central sympatholytic, also used in the sleep rotation stack. 0.05–0.1mg. Prescription required.

Prazosin — alpha-1 blocker for acute catecholamine surges. Keep at bedside, not for nightly use. Different mechanism from clonidine — peripheral not central. 2mg at surge onset. Prescription required.

Cross-Pillar

Sleep — The Rotation Stack

Sleep is the single most important variable in BIND recovery. The strategy that works isn’t finding one sleep intervention and sticking with it — it’s rotating between several, never staying on any one long enough to develop tolerance. Each agent below works through a different mechanism.

Mirtazapine

Best Sleep Intervention

The single best sleep intervention I’ve found. H1 antagonism produces genuine sedation. Alpha-2 antagonism reduces autonomic arousal. Also reduces mast cell histamine release and has confirmed trigeminal anti-sensitization effects. [J. Orofacial Pain 2011] The combination makes it uniquely suited to BIND sleep disruption, which is driven by both arousal and sensitization simultaneously.

Prescription required. Didn't see significant results until 30mg in my experience. Rotated with other agents to prevent tolerance.

Clonidine

Worked Well

Alpha-2 agonist suppressing locus coeruleus norepinephrine output. Directly addresses adrenergic hyperactivation that drives early-morning waking and cortisol surges in CRH-predominant BIND. Particularly useful for the wired, adrenaline-flooded state that makes sleep impossible regardless of how tired you are.

Prescription required. Low doses (0.05–0.1mg). Blood pressure monitoring recommended.

Gabapentin

Worked Well

Calcium channel modulation reducing neuronal excitability — addresses excitatory overload through a different mechanism than antihistamines or adrenergic agents. Tolerance develops quickly with sustained use, which is exactly why rotation is essential. Never use nightly for extended periods.

Prescription required. Low doses for sleep. Rotate with other agents.

Antihistamines (Rotating)

Useful

First-generation antihistamines produce sedation via H1 blockade and address mast cell-driven sleep disruption — relevant for MCAS-overlap presentations. Tolerance develops quickly. Rotate between hydroxyzine, diphenhydramine, doxylamine, and with the rest of the stack.

Hydroxyzine requires prescription; others OTC. Rotate between agents. Never rely on any single one nightly for more than a few days.

Also useful for sleep — gentler, OTC options worth rotating:

  • Kanna (Sceletium tortuosum) — helped with sleep, sensitivity reduction, and calming that wired BIND baseline. PDE4 inhibition and serotonin reuptake modulation. ~150mg. Source quality varies widely. Rotate — tolerance develops with daily use.
  • Magnolia Bark (honokiol/magnolol) — GABA-A positive allosteric modulator and CB2 agonist. Genuinely calming with real anxiolytic and sleep-promoting effects. Helpful for a period in my experience. Rotate with other agents — tolerance develops.
  • Liposomal Apigenin — flavonoid GABA-A modulator (the active compound in chamomile, in a bioavailable form). Gentle sleep support and anxiolytic. Liposomal delivery matters for absorption. Mild but consistent effect. Well-tolerated.
  • CBD (cannabidiol) — anxiolytic, mast cell stabilizing, mild sleep support. Highly variable by product quality — full-spectrum from a reputable source only. Some people with BIND find it activating rather than calming. Test carefully.
  • Progest-E (progesterone in vitamin E oil) — progesterone converts to allopregnanolone in the brain, a potent endogenous GABA-A positive modulator — the same receptor site targeted by benzos, but without dependence or tolerance. [PubMed 1997] Particularly interesting for BIND given that benzo withdrawal disrupts neurosteroid production. Transdermal or sublingual application. Worth researching carefully for your own hormonal context.

The rotation principle: The goal is to never take any single sleep aid long enough to develop tolerance, while maintaining enough sleep quality to support recovery. Each agent in this stack targets a different mechanism — rotating between them means each one retains efficacy when you return to it. Most require a prescribing provider, which is one reason having a psychiatrist or naturopath in your team matters.

Didn’t work for me — may work for you

These have solid mechanistic rationale for BIND and come up in the community. Worth knowing about even though they didn’t move the needle significantly for me.

  • Phosphatidylserine — dampens evening cortisol rise, HPA axis rhythm support. Mild effect. Worth trying for CRH-adrenergic presentations.
  • Ashwagandha (KSM-66) — GABA-A modulation, cortisol reduction, HPA axis support. Some find it genuinely helpful; others with MCAS get paradoxical stimulation. Careful tolerance test warranted.
  • P5P (Pyridoxal-5-Phosphate) — active B6, cofactor for GABA synthesis enzyme. Theory solid; bottleneck in BIND isn’t the enzyme. Limited impact.
  • B-Complex (methylated) — methylcobalamin (B12), methylfolate, P5P, riboflavin. Support methylation cycle, mitochondrial function, and myelin. Take in the morning only — B vitamins can be activating. Methylated forms preferred for anyone with MTHFR variants.
  • Zinc — NMDA receptor co-factor, immune support, anti-inflammatory. Many people with chronic illness are depleted. Separate from NAC by 2 hours (NAC chelates zinc). Zinc picolinate or bisglycinate forms preferred.
  • Selenium — glutathione peroxidase co-factor, thyroid support, antioxidant. Selenomethionine form. Important for detox pathway function and often depleted in chronic illness.
  • Vitamin D3 + K2 — immune modulation, neurological function, mood. Most people with BIND are deficient. Test before supplementing. K2 (MK-7) directs calcium appropriately. Take with fat.
  • R-ALA (R-Alpha Lipoic Acid) — mitochondrial antioxidant, glutathione recycling, Nrf2 activation. Separate from minerals by 2 hours (chelation). R-form specifically — significantly more bioavailable than racemic ALA. Not morning if cortisol is already low.
  • Lion’s Mane — NGF (nerve growth factor) stimulation, myelin support, neuroplasticity. Active in my current protocol. Mild but consistent cognitive support. Take in the morning.
  • Reishi (Ganoderma) — Th2 immune skewing, microglial regulation, HPA axis modulation. Anti-neuroinflammatory and adaptogenic. Rotate every 3–4 days — not daily. Synergistic with the broader anti-inflammatory stack.

This page will keep growing.

As I learn more, try more, and hear from the people I work with, I’ll add to it. If you want structured help figuring out what to try first for your specific presentation — that’s what the coaching is for.

Sessions &
Access

No one is ever turned away for lack of funds. Start there.

The most important thing on this page

The scholarship is real.
Full sessions. Pay what you can.

BIND takes jobs. It takes savings. It takes the ability to work. The people who most need support are often the least able to pay for it. If money is a genuine barrier — the scholarship exists for exactly that.

How sessions work

01
30-minute intake sessionI review your intake form beforehand, map your phenotype, and we build your initial framework together. You leave with one specific, well-reasoned intervention targeted to your presentation.
02
Written follow-up within 24 hoursSourcing, dosing protocol, what positive response looks like, what to watch for. Everything you need to actually try the thing we discussed.
03
Text or email access all weekQuestions about what you're trying? Reactions you're not sure about? Reach out. Brief, direct responses — real support without the hand-holding.
04
15-minute follow-ups from thereBook again whenever you're ready. Did it work? Good. Didn't? Here's why, and here's what's next. Short, efficient, iterative.
First Session

Intake Session

$100–200 / 30 min · includes a week of text & email access · sliding scale

Your first session is different. I review your intake form beforehand, identify your dominant phenotype, and we build your initial framework before landing on your first intervention.

  • 30-minute video or phone call
  • Intake form reviewed in advance
  • Phenotype identification & framework overview
  • One targeted first intervention
  • Written follow-up email within 24 hours
  • Text / email access for the week
Follow-Up Sessions

15-Minute Check-In

$50–150 / session · includes a week of text & email access · sliding scale

Report back on what you tried. Iterate. Get the next thing. Short, efficient, actionable — the core of the ongoing relationship.

  • 15-minute video or phone call
  • Review what you tried & your response
  • Next intervention or protocol adjustment
  • Written follow-up email within 24 hours
  • Text / email access for the week
  • Book as often or rarely as you need
Community

Monthly Office Hours

$15–20 / session · sliding scale

Open Q&A and community learning. Bring your questions, hear others'. Drop in anytime — no commitment required.

  • Up to 60-minute monthly Zoom call
  • Open Q&A — bring anything
  • Topic deep-dive each session
  • Learn from others' questions
  • Recorded for those who can't attend live

Ongoing support

Start with a single session. If you want to keep working together — weekly or every other week — these packages bundle sessions with guaranteed messaging access throughout the month.

Weekly

Weekly Check-In

$150–550 / month · sliding scale

One 15-minute session per week, plus ongoing text and email access. Best for active experimentation and fast iteration.

  • 4 x 15-minute sessions per month
  • Written follow-up after every session
  • Text & email access all month
  • Response within 48 hours
  • Running protocol log between sessions
  • Monthly office hours included
  • Cancel anytime — no contracts
Bi-Weekly

Bi-Weekly Support

$100–280 / month · sliding scale

One session every two weeks, plus messaging access throughout. Good rhythm for people who need time to run each intervention before reporting back.

  • 2 x 15-minute sessions per month
  • Written follow-up after every session
  • Text & email access all month
  • Response within 48 hours
  • Running protocol log between sessions
  • Monthly office hours included
  • Cancel anytime — no contracts

A note on what to pay.

This isn't my primary work. I'm a meditation teacher and I run a native plant nursery. I'm doing this because I remember exactly what it felt like to be in the depths of BIND with no one willing to actually engage — and I want to help a few people who are in that place. Money is not the point. Access is.

If you can contribute something, pay what honestly fits your situation. If you can't — the scholarship exists, and that's what it's for.

Scholarship
Application

No income verification. No embarrassment. Just a short form so I can get you scheduled.

BIND takes jobs. It takes savings. It takes the ability to work. The people who most need support are often the least able to pay for it. The scholarship exists to fix that. If money is a genuine barrier — this form is for you. Fill it out and you'll be scheduled exactly like any other client. No catch, no trial period, no expectation that you'll eventually pay.

I'll be in touch when sessions open in Fall 2026. You'll be at the front of the line. If your situation changes later and you want to contribute something, that's always welcome — but never required or expected.

Resources &
Writing

Education, interventions, and honest explorations of what's working in BIND recovery.

Real information. No empty reassurance.

Written for people who want to understand their recovery — not just survive it. Mechanistic depth alongside the spiritual and human dimensions of healing.

🌿
Personal

Been to Hell and Back: Love Is Still at the Center of Everything

A wilderness retreat, a heat exhaustion injury, the death of my brother, benzodiazepine withdrawal, and what I found at the bottom of all of it.

Published 2026
⚖️
Personal

Do Nothing or Try Everything? Finding the Middle Way in BIND Recovery

The BIC told me there's nothing you can do. I was in my parents' basement unable to move. Here's what I learned about the real cost of both extremes.

Published 2026
🧠
Neuroscience

What BIND Actually Is: A Plain-Language Guide to the Mechanisms

GABA, NMDA, neuroinflammation — what's happening in your nervous system and why it matters.

Published 2026
📢
Advocacy

An Open Letter to the FDA and HHS: The Benzodiazepine Crisis Is Not Over

Millions of Americans are injured, dependent, and abandoned. The opioid epidemic got headlines and funding. This one gets silence.

Published 2026
⚕️
Essay

You Are Not an Addict. You Are Injured.

On the difference between addiction, dependence, and neurological injury — and why that distinction changes everything about how you seek help and whether you get it.

Published 2026
🌿
Nature Healing

Why Nature Isn't Just Good Advice — It's Nervous System Medicine

The research on nature and autonomic regulation, practically applied to BIND.

Published 2026
☸️
Meditation

Buddhist Practice in BIND Recovery: Impermanence as Medicine

How the teachings on impermanence become survival tools in neurological injury.

Published 2026
🌿

Sessions opening Fall 2026

I'm still in my own recovery and not yet taking clients. The site and all resources are here now — free to use. Join the waitlist and I'll reach out when sessions open.

Join the
Waitlist

Sessions open Fall 2026. Leave your email and I'll notify you when booking opens — no spam, one email.

While you wait

Everything on this site is free to use right now — no booking required. The Framework, What Works, Testing, and About pages are all live and open.

If you're in the depths of it right now and can't wait until fall, the free resources are a genuine starting point. The Framework page in particular lays out the mechanistic picture and the four-stage protocol in enough detail to start experimenting on your own.

📖
Read the Framework — phenotypes, pillars, protocol
🧪
See everything I've tried — free
🔬
Recommended lab testing — free
📅
Office hours planned for Fall 2026 alongside individual sessions
✉️
justin.michelson@gmail.com — for anything that doesn't fit a form

I'm posting this site before I'm fully recovered because the information is needed now and the recovery journey is mine whether or not I'm coaching. When I'm ready to take clients — probably fall 2026 — I'll be coming from the other side of this, not the middle of it.

Join the waitlist

One email when sessions open. That's it. No newsletter, no marketing.

Have a question in the meantime?

Recommended
Testing

Labs that actually inform treatment. Free to use — bring this list to your naturopath or order directly.

How to use this page: These are the tests I consider most useful for building an informed BIND recovery protocol. Most can be ordered through a naturopath or functional medicine doctor. Several can be ordered directly without a provider through services like Ulta Lab Tests or Request A Test. None of this is a substitute for working with a qualified provider — it’s a starting point for an informed conversation with them.

The difference between guessing and targeting.

Most BIND recovery happens in the dark — people try things based on what worked for others, with no data about their own specific presentation. Two people with identical symptoms can have completely different underlying drivers: one has inverted cortisol and mitochondrial dysfunction, another has mast cell activation and autoimmune neuroinflammation. The same intervention may help one and worsen the other.

A targeted lab panel changes that. Start cheap and basic. Add the more specialized panels based on what your presentation suggests.

🥇

Start Here — Basic, Cheap, Run on Everyone

Comprehensive Metabolic Panel + CBC

Baseline

Liver enzymes, kidney function, blood glucose, electrolytes, and complete blood count. Essential baseline before starting most supplements or protocols. Liver health matters for anyone doing peptides, higher-dose supplements, or anything that taxes detox pathways.

Any standard lab (LabCorp, Quest). ~$30–60. Should be repeated periodically.

Magnesium RBC

High Priority

Not serum magnesium — that test is nearly useless and can be normal even with severe intracellular deficiency. Red blood cell magnesium reflects actual tissue status. Deficiency is nearly universal in BIND and directly impairs NMDA receptor function and GABAergic tone. Cheap, widely available, and the result changes first-line supplement recommendations immediately.

Any standard lab. ~$30–60. Specify RBC magnesium explicitly.

Vitamin D (25-OH)

Baseline

Deficiency worsens neuroinflammation, immune dysregulation, and autonomic instability — all central BIND mechanisms. Extremely common and cheap to correct. Target 60–80 ng/mL for neurological support, not the conventional “normal” range.

Any standard lab. ~$40–80.

Full Thyroid Panel

High Priority

TSH alone is inadequate. Order: TSH, Free T3, Free T4, Reverse T3, and TPO antibodies. Thyroid dysfunction — including Hashimoto’s — is chronically underdiagnosed, mimics and amplifies BIND symptoms across nearly every domain (sleep, cognition, anxiety, fatigue), and is treatable. Don’t let a normal TSH end the conversation.

Standard labs. ~$100–200 for full panel.

Inflammatory Markers (hsCRP, Homocysteine, Ferritin)

Cheap Add-Ons

Inexpensive markers that add meaningful context. Elevated hsCRP suggests active systemic inflammation. Elevated homocysteine points to methylation issues and is an independent neurological risk factor. Ferritin informs iron status and inflammation simultaneously.

Any standard lab. ~$30–80 combined.

CYP2D6 / CYP2C19 Genotyping

Critical if Medicating

If you’re taking or considering anything that goes through CYP450 pathways — and most psychiatric medications and substances like iboga do — knowing your metabolizer status changes everything. Poor metabolizers accumulate drugs to unexpectedly high levels. This is one of the most clinically important pieces of data for BIND protocol design.

GeneSight, Genomind, or via LabCorp/Quest pharmacogenomics panels. ~$100–300, sometimes covered by insurance.

🛡️

Autoimmune & Neuro-Autoimmune

Cyrex Array 5 — Systemic Autoimmunity

Neuro-Autoimmune

Screens for autoantibodies to a wide range of tissues including neural tissue. Relevant for complex BIND presentations with a suspected autoimmune component — persistent neurological symptoms that don’t follow a typical recovery trajectory, or presentations overlapping autoimmune encephalitis or post-viral syndromes.

Cyrex Laboratories via provider. ~$400–600.

Cyrex Array 20 — Blood-Brain Barrier Permeability

Neuroinflammation

Measures markers of BBB integrity — whether the barrier is allowing passage of substances that should be excluded. Directly relevant to neuroinflammatory BIND presentations. A normal result is reassuring; an abnormal result points toward interventions that support barrier repair (TB-500, BPC-157, GHK-Cu).

Cyrex Laboratories via provider. ~$300–400.

Voltage-Gated Calcium Channel Antibodies

Autonomic Presentations

Relevant for presentations with strong autonomic or neuromuscular features. VGCC antibodies have been associated with autoimmune autonomic ganglionopathy and Lambert-Eaton-like presentations. Worth considering if the autonomic component is severe and doesn’t respond to standard approaches.

LabCorp or Mayo Clinic via provider. ~$200–400.

🦠

Infection & Chronic Pathogen Load

Lyme & Co-infections Panel

If Exposure Possible

Chronic Lyme disease and co-infections (Bartonella, Babesia, Ehrlichia) produce a neurological picture that overlaps significantly with BIND — cognitive dysfunction, autonomic dysregulation, neuroinflammation, hypersensitivity. Standard Lyme tests miss many cases. If there’s any tick exposure history or the presentation has persistent unexplained features, this is worth pursuing through a specialty lab.

IGeneX or Galaxy Diagnostics for comprehensive panels. ~$300–600. More sensitive than standard Quest/LabCorp Lyme screens.

EBV / HHV-6 / CMV Reactivation

Viral Load

Chronic herpesvirus reactivation — particularly EBV and HHV-6 — is increasingly recognized as a driver of neuroinflammation, fatigue, and immune dysregulation. These viruses don’t necessarily cause acute illness but can maintain a low-grade neuroinflammatory state. Worth checking if fatigue is disproportionate or the inflammatory picture doesn’t have another clear explanation.

LabCorp or Quest via provider. Check IgG/IgM and early antigen markers. ~$100–200.

Mold / Mycotoxin Panel

If Exposure Suspected

Mold exposure is massively underdiagnosed as a BIND amplifier. It shares overlapping mechanisms — neuroinflammation, mast cell activation, mitochondrial dysfunction — and can make a recovering BIND presentation dramatically worse. If there’s any history of water-damaged buildings or persistent multi-system symptoms that don’t improve, this is worth running.

Great Plains Laboratory (MycoTOX) or Vibrant Wellness. ~$300–400. Can be ordered directly without a provider.

🧪

Mast Cell & Histamine

Serum Tryptase

MCAS Screening

Elevated baseline serum tryptase supports systemic mastocytosis or MCAS. Must be drawn during or within 4 hours of a reaction for accuracy — baseline tryptase alone is often normal in MCAS. Useful as part of a broader picture rather than a standalone rule-out.

Any standard lab. ~$50–100. Timing matters.

DAO Enzyme & Histamine Panel

Histamine Burden

Diamine oxidase (DAO) is the primary enzyme that breaks down histamine. Low DAO activity combined with high histamine load drives the mast cell-NMDA feed-forward loop central to many severe BIND presentations. If flushing, food reactions, or chemical sensitivities are prominent, this adds meaningful data.

Dunwoody Labs or similar functional labs. ~$150–250.

Prostaglandin D2 & Urine Histamine

MCAS Confirmation

24-hour urine collection measuring histamine metabolites and prostaglandin D2 — mast cell mediators that provide stronger evidence of MCAS than serum tryptase alone. More cumbersome but more specific. Worth doing if MCAS is strongly suspected and you want data to support treatment decisions.

Mayo Clinic or National Jewish Health via provider. ~$200–400.

🔬

GI, Hormones, Heavy Metals & Deeper Functional

DUTCH Complete

High Priority

Dried urine test covering the full cortisol curve including the cortisol awakening response, sex hormones, melatonin metabolites, and organic acid markers. The cortisol pattern in BIND is often inverted — low morning, rising evening, absent awakening response. Standard serum cortisol misses most of this. Knowing this changes your intervention approach significantly.

DUTCH Test (dutchtest.com) via provider. ~$300–400.

Organic Acids Test (OAT)

High Information

One of the highest-information single tests available. Covers mitochondrial function, neurotransmitter metabolites, oxalate load, B vitamin status, markers of gut dysbiosis, and candida overgrowth. A single urine sample that paints a detailed picture of what’s happening at the cellular level.

Great Plains Laboratory or Mosaic Diagnostics. ~$300.

Comprehensive Stool Analysis (GI-MAP)

GI Involvement

PCR-based stool test measuring bacterial balance, pathogens, parasites, fungal overgrowth, and markers of intestinal inflammation (calprotectin, secretory IgA). The gut-brain axis is central to BIND — gut dysbiosis both reflects and perpetuates neuroinflammation. If GI symptoms are prominent or nothing else is explaining the picture, this adds important data.

Diagnostic Solutions Lab (GI-MAP) via provider. ~$300–400.

Heavy Metals Panel (Hair or Urine)

Toxic Load

Heavy metal accumulation — lead, mercury, arsenic, cadmium — drives neuroinflammation and mitochondrial dysfunction through mechanisms that directly overlap with BIND. Mercury in particular has a high affinity for neural tissue. Hair elements and provoked urine testing (with DMSA or DMPS challenge) give different windows into total body burden.

Doctor’s Data (hair elements) or Genova Diagnostics (urine metals). ~$150–300. Provoked testing requires a provider.

Urinary Neurotransmitter Panel

Useful With Caveats

Measures GABA, glutamate, serotonin, dopamine, norepinephrine from urine. Important caveat: urinary neurotransmitters reflect peripheral production, not CNS levels directly. GABA in urine doesn’t equal brain GABA. That said, the glutamate/GABA ratio still provides a useful signal of systemic excitatory/inhibitory balance, and many people with BIND see a dramatically skewed ratio that validates their experience. Treat it as one data point, not a definitive readout. For actual CNS data, MRS (Magnetic Resonance Spectroscopy) is the research-grade option.

ZRT Laboratory, Sanesco, or Doctor’s Data via provider. ~$200–350.

Want help interpreting your results?

Lab interpretation in the context of BIND is where coaching adds the most value. What looks normal on paper can be clinically significant for a sensitized nervous system — and vice versa. Join the waitlist for fall 2026 sessions.

You Are Not an Addict.
You Are Injured.

On the difference between addiction, dependence, and neurological injury — and why it matters more than almost anything else.

The word that gets attached to benzo-injured people, sometimes by their doctors, sometimes by their families, sometimes by themselves, is “addict.” It is the wrong word. It is not a small mistake. It changes everything about how people understand what happened to them, how they seek help, and whether they get it.

I want to be as precise as I can here, because precision matters.

Three different things that get called the same thing

Addiction is a behavioral and psychological phenomenon. It involves compulsive drug-seeking despite harmful consequences, often involving psychological craving and reward-circuit dysregulation. Addiction can happen with benzos. It is not what happens to most benzo-injured people.

Physical dependence is a pharmacological phenomenon. It means the body has adapted to the presence of a substance and will go through withdrawal when that substance is removed. Physical dependence is a predictable, dose-dependent outcome of taking benzodiazepines for more than a few weeks. It happens to nearly everyone who takes them regularly. It is not a character flaw. It is not a choice. It is what GABA receptors do when chronically exposed to a substance that artificially amplifies their activity. They downregulate. They compensate. Then the drug disappears and the compensation has nothing to compensate against.

Neurological injury is something else again. It is what happens when the process of dependence and withdrawal damages systems that don’t simply recover on their own timetable. The sensitization becomes structural. The NMDA upregulation, the autonomic dysregulation, the mast cell activation, the trigeminal sensitization — these aren’t withdrawal. Withdrawal ends. This doesn’t. Or it does, eventually, but on a timescale and with a complexity that the word “withdrawal” doesn’t begin to capture.

Most benzo-injured people are in category three, having passed through category two, having never been in category one at all.

What happens when you use the wrong word

I took lorazepam for one month. At prescribed doses. For a legitimate medical reason. I was not seeking euphoria. I was not escalating my dose to chase a high. I was trying to sleep after a heat exhaustion injury had left my nervous system destabilized. When I stopped — too quickly, on a two-week taper that my nervous system couldn’t tolerate — I became neurologically injured.

If you describe what happened to me as addiction, you have said something false. You have also, in the same breath, made it dramatically harder for me to get help. Addiction treatment and BIND treatment are not the same thing. An addiction counselor has no framework for what I was experiencing. A doctor who hears “benzodiazepine addiction” treats a different condition than the one I had.

The conflation doesn’t just stigmatize. It actively misdirects care.

Why the medical system makes this mistake

Medicine has, for decades, bundled physical dependence together with addiction under the category of “substance use disorder.” This made a certain administrative sense. Both involve substances. Both involve some kind of problematic relationship with a drug. But the mechanisms are different, the populations are different, the treatments are different, and the moral valence — which should be absent from both — has been applied almost exclusively to the dependence/injury group, the people who were simply following their prescriptions.

There is also a less flattering explanation. Calling benzo-injured patients addicts protects the system that injured them. If you become dependent on a drug your doctor prescribed, in the way your doctor told you to take it, the injury belongs somewhere. Calling it addiction places it inside you — in your psychology, your choices, your predisposition. Calling it injury places it in the prescribing practice, the inadequate taper guidance, the regulatory failures that allowed millions of people to be put on drugs with a known dependence-and-injury profile without adequate informed consent. The first framing is more comfortable for everyone except the patient.

What it means to know you are injured

Something changes when you understand what actually happened to your nervous system. Not everything changes — the symptoms are still there, the recovery is still uncertain, the difficulty is still real. But the framework shifts. You are not someone who got addicted. You are someone who was injured by a prescription. Those are different situations with different implications, different treatment approaches, and a different relationship to blame and shame.

The shame is one of the most damaging aspects of BIND that nobody talks about. People who are suffering enormously, who are doing everything right, who are trying their hardest to recover, are also carrying around a story that what happened to them reflects something about who they are. It doesn’t. It reflects something about pharmacology, about prescribing culture, and about a medical system that has been slower than it should have been to take this seriously.

You were injured. That is the accurate word. And injured people deserve care — not judgment, not skepticism, not redirection to addiction services that weren’t designed for them. Care.

That’s all this site is trying to offer. A place that starts from that premise and goes from there.

Community &
Resources

You are not alone in this. These are the organizations, communities, books, and references that have mattered in BIND recovery.

This site is one resource. The BIND community has been building knowledge collectively for decades — long before there was a name for what was happening. The people who built these communities are the reason any of us know what BIND is. Use them.

🤝

Peer Support & Community

Benzodiazepine Information Coalition

Essential

The most important advocacy and education organization in the BIND space. Run largely by people with lived experience, with strong scientific and medical advisors. The place to start if you want to understand BIND from a credible, patient-centered perspective. Their resources are free and accurate.

benzoinfo.com

Benzo Buddies

Peer Forum

The longest-running peer support forum for benzodiazepine withdrawal and BIND. Thousands of threads, years of community knowledge. Invaluable for knowing you are not alone and for learning what others have experienced. Read with the same critical thinking you'd apply anywhere — anecdotes are data points, not prescriptions.

benzobuddies.org

r/benzorecovery

Community

Active Reddit community for benzo withdrawal and recovery. More current than some of the older forums. Good for finding people with similar presentations and hearing what's working in real time. Like all Reddit communities, quality varies — use your judgment.

reddit.com/r/benzorecovery

Alliance for Benzodiazepine Best Practices

Advocacy

The organization that convened the Benzodiazepine Nosology Workgroup — the 23-expert panel that coined the term BIND in 2023. Their work on nomenclature and clinical guidelines is the foundation for getting BIND taken seriously in medical settings.

benzoreform.org

📚

Essential Reading

The Maudsley Deprescribing Guidelines

Current Best Reference

The most current and comprehensive clinical reference for safely stopping benzodiazepines, antidepressants, gabapentinoids, and z-drugs. Authored by Dr. Mark Horowitz and Professor David Taylor and published by Wiley in 2024. Evidence-based, covers hyperbolic tapering, protracted withdrawal, and troubleshooting — things the Ashton Manual predates. This is what you hand your doctor. Endorsed by the Benzodiazepine Information Coalition.

Available on Amazon — Horowitz & Taylor, Wiley 2024

The Ashton Manual

Foundational — Older

Professor Heather Ashton's guide to benzodiazepine withdrawal, written in 2002 by a physician who ran the first benzodiazepine withdrawal clinic. Still widely cited and historically important — the Maudsley guidelines build on it. Free online. Worth reading for the foundational tapering principles, with the caveat that the science has moved significantly since 2002.

benzo.org.uk/manual — free

Ritvo et al. (2023) — The BIND Paper

Peer-Reviewed

The PLOS ONE paper that coined the term BIND and published the largest-ever survey of benzodiazepine users (1,207 respondents). Establishes the scientific grounding for BIND as a distinct and serious neurological condition. Share this with any provider who tells you it isn't real.

Read on PMC — free, peer-reviewed

The Dharma of Healing

By Justin Michelson

My book, published by Shambhala Publications. It weaves Buddhist wisdom, contemplative practice, and the lived experience of serious illness into a framework for healing that goes beyond the physical. Written through my own injury. Not a BIND manual — something more foundational than that. For the spiritual and existential dimensions of what you're going through, especially if meditation and meaning are part of your toolkit.

Available on Amazon — Shambhala Publications

🔬

Research & Clinical Resources

BIND Specialists — Finding Them

Provider Search

Providers who genuinely understand BIND are rare. The BIC maintains a provider directory of practitioners who have expressed willingness to work with benzo-injured patients. It is not a quality guarantee — do your own due diligence — but it's a starting point. Naturopaths, integrative psychiatrists, and functional medicine practitioners tend to be more receptive than conventional physicians.

BIC Provider Directory

Dr. Valsa Madhava

BIND Specialist

One of the very few physicians in the US with specific clinical expertise in protracted benzodiazepine withdrawal and BIND. Published researcher. Has developed a phenotype-based classification system for BIND presentations. If you can access her care, she's one of the most knowledgeable clinicians working in this space.

Dr. Mark Leeds

BIND Specialist

Addiction psychiatrist with specific expertise in benzodiazepine dependence and withdrawal. One of the practitioners willing to work with complex BIND presentations, including those with long post-taper courses. Telehealth available in some states.

If you are in crisis

BIND can produce despair that feels absolute. It is not. The nervous system that is generating those feelings is injured — those feelings are symptoms, not facts about your future. People recover from exactly where you are.

988 Suicide & Crisis Lifeline: Call or text 988 — available 24/7. Crisis Text Line: Text HOME to 741741.

Been to Hell and Back:
Love Is Still at the Center of Everything

A personal essay on wilderness, heat exhaustion, my brother's death, benzo withdrawal, and what I found when I got to the bottom.

I want to tell you something I can confirm from the inside of genuine hell. Not metaphorical hell — actual neurological, psychological, spiritual hell. The kind where you can't sleep for months, where your mind generates images so foreign to everything you are that you can't believe they're yours, where your body has become your enemy and every system that was supposed to protect you has gone haywire.

What I can confirm is this: love is still at the center of everything. It didn't fix anything. It didn't override the nervous system. But it was there. It kept showing up. And that matters more than I know how to say.

The retreat

About a year before everything fell apart, I went on a month-long wilderness meditation retreat. Alone, in the heat of summer, sitting with the deepest questions I knew how to ask. The central one, the one I kept returning to, was something like: what does it actually mean to rest in deep okayness with everything? Not as a philosophy. Not as a teaching I wrote about or offered to others. But as something lived, embodied, real — in the cells, in the moment, in the face of whatever arises.

I had just finished writing The Dharma of Healing. I had spent years thinking and writing about emotional healing, compassion, the relationship between Buddhist practice and the body, the way love is more foundational than suffering. Now I wanted to stop writing about it and just be in it.

The heat that summer was brutal. By the end of the retreat, I had heat exhaustion. My nervous system was already destabilized in ways I didn't fully understand yet. I came home depleted in a way that felt different from ordinary tiredness.

The unraveling

What followed was five months of anxiety and insomnia unlike anything I had experienced. I am — and have always been — a soft, sensitive, gentle person. I don't say that as a compliment to myself; it's just true. I've spent my adult life oriented toward kindness, toward nature, toward contemplative practice. I had never been on a pharmaceutical in my life.

And then, a month before things got truly bad, my brother died.

He had struggled for years with his psychological health — medications, psychosis, the long difficult road that so many people walk in the shadow of serious mental illness. I watched him move through systems that were supposed to help and often didn't. And then he was gone.

I was already not sleeping. Already barely functioning. And then I was also grieving, and the two things together — the sleeplessness, the loss, the nervous system already fraying at the edges — created a kind of perfect storm. Eventually I was put on benzodiazepines. For a month. By a doctor who meant well.

That month injured me.

The hell

Benzo withdrawal is unlike anything I had a framework for. The physical symptoms were bad enough — the autonomic surges, the hypersensitivity, the way every sense felt tuned to a frequency that made ordinary life unbearable. But what I wasn't prepared for were the intrusive thoughts.

Violent images. Disturbing scenarios. Content so contrary to everything I am that I couldn't believe it was coming from my own mind. It was as though all the suffering in the world had found a way inside — all the hell, all the darkness, all the things I had spent my life turning away from in quiet and in practice, suddenly present and insistent.

I want to be honest about how bad this was. I am not someone who dramatizes. This was the darkest place I have ever been. The combination of no sleep, profound grief, neurological injury, and a mind generating content I didn't recognize as mine — it was an absolute trial of everything I believed, everything I had written about, everything I thought I understood about healing and love and the capacity of practice to hold suffering.

What I found at the bottom

Here is what I found: love showed up.

Not as a feeling. Not as warmth or comfort or the cessation of pain. But as something more foundational than any of that — as the ground under the ground, present even when everything on top of it was unbearable. I kept surrendering into it. I kept letting go of the desperate wish for things to be different and dropping into whatever was actually there beneath the suffering. And what was there, underneath everything, was this: love. Still there. Still holding.

But I also want to be honest about what it didn't do.

It didn't fix my nervous system. I might practice all night — really practice, with real intention and real surrender — and still not sleep. The nervous system, when it's genuinely dysregulated, doesn't respond to spiritual effort. It responds to biology. And that was one of the most humbling realizations of my life.

I knew this intellectually. I had written about the relationship between physical health and emotional and spiritual life. I knew that the body matters, that the nervous system is not just a vehicle for consciousness but a shaping force in experience. But knowing it and living it are different things. Living it looked like: I can be genuinely at peace, genuinely resting in love, genuinely present — and still not sleep. Still feel the burning and the surging and the hypersensitivity. Still have the intrusive thoughts moving through like weather I couldn't stop.

I think of a teacher I deeply respect — someone with decades of serious practice, someone who has helped thousands of people. He had nerve pain for twenty years. He is now on anti-anxiety medication. He had to retire. The nervous system, when it is truly injured, dominates. That is not a spiritual failure. That is a biological fact.

What love actually did

What love did — what it actually, practically did — was make it possible to keep going.

Not without suffering. Not without the full weight of what was happening. But with something underneath it that didn't collapse. I found that even the intrusive thoughts, even the violent images and the darkness that felt so foreign — even those were love. Distorted, yes. Frightened, yes. But love at the root, reaching for something, trying to process what couldn't be processed through ordinary channels.

My way of being with them was to say, quietly: hello, love. I see you. I know you. Not engaging with the content. Not fighting it. Not being afraid of it. Just recognizing what was underneath it and meeting it there.

That practice — that specific, quiet, stubborn recognition — was what kept me from being destroyed by it. Not because it made the symptoms go away. It didn't. But because it meant I was never entirely alone in it. There was always something to return to.

And alongside that practice — equally important, equally necessary — was the other part of me that refused to stop looking for a way through. The part that said: I need to understand what's happening in my nervous system. I need to find out what might help. I cannot stay in this place forever. I will not accept that nothing can be done.

Those two things together — the surrender into love and the refusal to stop problem-solving — are what got me through. Neither one was enough alone.

Why I'm writing this

I'm writing this because I think it's important for anyone going through BIND — or any serious neurological suffering — to hear both parts of this clearly.

Your practice matters. Meditation, presence, surrender, love — these are real and they are not nothing. They may be the thing that keeps you intact at the center when everything else is falling apart. But they will not override a broken nervous system. They are not supposed to. The body is real. The biology is real. The injury is real. And it requires real interventions alongside everything else.

The good news — the thing I can actually confirm from the inside of this — is that love is more foundational than all of it. More foundational than the nervous system, more foundational than the suffering, more foundational than the hell itself. It doesn't always feel that way. In the worst moments it doesn't feel that way at all. But it's there. It keeps showing up. It held me when nothing else could.

I don't know exactly when I'll be fully recovered. I'm still in it. But I'm not in the deepest hell anymore. I got through the bottom. And what I found there is worth sharing.

Love is still at the center of everything. I can confirm it.

Do Nothing or Try Everything?
Finding the Middle Way in BIND Recovery

The official advice was to do nothing. I was getting worse by the month. Here's what I learned about the real cost of both extremes.

I want to talk about something nobody in the BIND community wants to say out loud. Because I've been to both extremes — doing nothing while I got progressively worse, and trying so many things so fast that I couldn't tell what was helping and what was hurting — and I think there's something important in the space between them that needs to be said honestly.

Two conditions nobody knows anything about

I came into this with two conditions stacked on top of each other. The first was a heat exhaustion injury from a month-long wilderness meditation retreat. Not a lot of people have good information about heat exhaustion as a neurological injury. It destabilizes the autonomic nervous system in ways that are poorly understood and poorly treated.

The second was benzodiazepine injury. I was put on lorazepam — Ativan — after five months of anxiety and insomnia following the heat exhaustion. For sleep. For one month. One month of prescribed use at prescribed doses. My doctor tapered me off in two weeks. That taper injured me. I found a psychiatrist who understood this and helped me get off more slowly — but by then the damage was already done. I was already injured on top of injured.

So I did what anyone would do. I went looking for information. I found the Benzodiazepine Information Coalition, which is one of the main resources in this space. I spoke with one of their experts. And they told me: there's nothing you can do. Don't try anything. Anything you try could set you back. But everyone heals.

Helpful and unhelpful at the same time. Helpful because it was the first real acknowledgment I'd gotten that what was happening to me was real and had a name. Unhelpful because I was in the middle of horror, and "wait and everyone heals" was not a plan I could survive on.

Six months of getting worse

Here's what I need to say about the "do nothing and heal" approach: for some people, it works. I've heard those stories. One day they wake up and the worst of it is gone. Or they suffer for a few months and then slowly it gets better. That's real. It happens.

That is not what happened to me.

For six months, I got progressively worse. Month by month, the symptoms deepened. The hypersensitivity increased. The sleep became more impossible. The neurological activation ratcheted up rather than down. I went from struggling to functioning, to struggling to leave the house, to eventually being in my parents' basement, in the dark, barely able to move.

I am not being dramatic. That is where I was.

And lying there, I had a realization that I think is important and that nobody wants to say: doing nothing is not neutral. It feels neutral, or even safe — because at least you're not risking making things worse with interventions. But if you are in a progressive neurological decline, doing nothing means allowing that decline to continue. The GABAergic dysfunction isn't just uncomfortable. It's excitatory. It's inflammatory. It builds on itself. The longer it goes unchecked, the deeper the hole you're in.

What I didn't have when I needed it most

I've thought a lot about what might have been different if I'd had better information earlier. The clearest example: if I had known about amanita muscaria in January — the month I was coming off benzos — things might have looked very different.

Amanita muscaria contains muscimol, which is a GABA-A agonist. The only non-addictive one that exists. It directly supports the inhibitory tone that benzos had been propping up artificially. Coming off benzos, the nervous system is in a state of GABAergic collapse — the receptors are downregulated, the system has nothing to lean on. That's what drives the excitotoxic cascade that causes so much of the damage.

If I had had a GABAergic floor in those early months, I might not have declined the way I did. I might not have needed to climb out of the basement. The early months of benzo withdrawal are when the trajectory gets set — and I had nothing supporting my inhibitory system while the excitatory pressure built and built and built.

Ketamine helped, and reset things for a while. But I kept having setbacks I didn't understand. Now I understand why: I had no floor. Every reset would begin to erode again because nothing was holding the GABAergic baseline. Amanita, or something like it, is what I needed — and I didn't know it existed.

The real cost of doing too much

But I also need to be honest about the other extreme. Because I've been there too.

I tried a lot of things. Some of them helped. Some of them did nothing. And some of them set me back in real and significant ways. Things that were too stimulating. Interventions I introduced too fast, at the wrong dose, in the wrong sequence. The BIND nervous system is a hypersensitive system — it reacts to everything, and not always in the direction you'd hope.

It takes courage to keep trying when things keep going wrong. Every time something sets you back — and things will set you back — there's a moment of reckoning. Do I keep going? Do I try the next thing? Am I making this worse? That uncertainty is exhausting on top of everything else.

I overdid it at times. I still do occasionally. Just recently I was going slowly with a new treatment — a mat that I was introducing carefully — and then I got sick, and in my desperation I increased the intensity too quickly. Couldn't sleep. Set myself back. Again.

It's a crazy balancing act. There are countless decision points. What do I try next? How much? When? And underneath all of it: is my body ready for this?

The thing nobody wants to say

Here it is: some people don't heal.

The hope-based communities — and I understand why they operate this way, and I don't entirely disagree with the approach — tend to say: everyone heals, you will heal, keep the faith. And you do have to keep the faith. You have to be able to imagine your future healed self pulling you forward. That mindset matters. I believe that.

But the other side of the truth is that some people go decades without healing. Some people have progressive neurological decline that doesn't reverse on its own. GABAergic dysfunction doesn't always stay as GABAergic dysfunction — it can lead to immune compromise, to autonomic disorders, to a whole cascade of downstream damage. It has for me. My immune system is compromised now in ways it wasn't before.

I'm not saying this to frighten anyone. I'm saying it because pretending it isn't true doesn't help the people for whom it's true. And those are exactly the people who most need real information and real options — not just reassurance.

The middle way

Someone told me something once that I've held onto: most people heal, but you can heal faster by supporting your body. I think that's it. That's the middle way.

Not: do nothing and trust the body completely.
Not: try everything you can find as fast as possible.
But: how do I actively support my body's healing capacity without overwhelming a system that's already overwhelmed?

That means one intervention at a time. It means tolerance testing. It means going slow enough to actually read the signal. It means having a floor — something providing basic stability — before you try to build on top of it. It means knowing when you're in a groove and knowing when you're spiraling, and responding differently to each.

A lot of what I use is intuition alongside analysis. I notice how my body responds to the idea of something. I ask, in whatever quiet way I can manage: how do you feel about this? Is this right for right now? It sounds imprecise, and it is — but after enough time in a sensitized body, you develop a kind of literacy for its signals that pure protocol can't replace.

The goal, for me, is to find the place where I'm sleeping — actually sleeping — and where I can exist in my life in a basic way. Not thriving yet. Just: sleeping, existing, not spiraling. From that place, healing is possible. From the basement in the dark, barely able to move, anything is possible but nothing is easy.

What I'd say to someone at the beginning

If you're early in BIND and someone tells you there's nothing you can do — I understand why they're saying it, and I understand the fear behind it. They've seen people hurt themselves by trying too much too fast. That fear is legitimate.

But I'd also say: do not let that advice become a reason to watch yourself decline for six months without trying to understand what's happening or find what might help. Passive waiting is not always safe. For some people, in some presentations, it allows a progressive process to continue unchecked.

Try to find a GABAergic floor as early as possible. Try to find sleep support. Try to find an anti-inflammatory intervention that your system can tolerate. Go slow. Test tolerance. Change one thing at a time. And keep the faith — not as denial, but as a genuine orientation toward the possibility of healing that you hold alongside a clear-eyed view of the reality in front of you.

Both things at once. That's the middle way.

An Open Letter to the FDA and HHS:
The Benzodiazepine Crisis Is Not Over

Millions of Americans are injured, dependent, and abandoned by the system that created this problem. The opioid epidemic got headlines, legislation, and billions in funding. This one gets silence.

To the Food and Drug Administration, the Department of Health and Human Services, and anyone else with the power to do something about this:

I am writing as someone who has been personally injured by benzodiazepines — prescribed legally, by a doctor following standard practice, for a legitimate condition. I am writing as someone who spent months in a state of neurological injury so severe I could barely move, who spent years climbing back from that, who is still not fully recovered. And I am writing as someone who has spent enough time in the research and the community to know that my story is not unusual. It is not rare. It is happening to millions of people right now, in this country, largely in silence.

This is a public health crisis. It is time to call it that.

The scale of the problem

30.6 million American adults report using benzodiazepines annually — that's roughly one in eight adults in this country. In 2019 alone, approximately 92 million benzodiazepine prescriptions were dispensed. In 2018, approximately 50% of patients prescribed benzodiazepines received a two-month or longer supply — despite decades of evidence that these drugs cause physical dependence within weeks and should not be used long-term.

Of those millions of users, a significant portion will develop dependence, face severe withdrawal, and some — by conservative estimates, somewhere between six and nine percent of all users — will develop what researchers now call BIND: Benzodiazepine-Induced Neurological Dysfunction. A complex, multi-system neurological injury that can last years. That is potentially 1.8 to 2.75 million new cases every year. In the United States alone.

For comparison: at the height of the opioid crisis, roughly 2 million Americans had an opioid use disorder. That number generated front-page coverage, congressional hearings, the SUPPORT Act, billions in settlement money, and a complete restructuring of how opioids are prescribed and monitored. The benzodiazepine crisis involves comparable numbers of injured people — and has generated, in proportion, almost nothing.

What the FDA has and hasn't done

I want to be precise about the regulatory history here, because it matters.

In 2010, a patient harmed by benzodiazepines submitted a Citizen's Petition to the FDA requesting a new boxed warning on benzodiazepine packaging. More than five years later, in 2015, the FDA rejected it. It took community organizing — the Benzodiazepine Information Coalition led a community-wide reporting drive through MedWatch in 2017, resulting in thousands of patients reporting their adverse events — before the FDA took notice.

In September 2020, the FDA finally required an updated boxed warning for all benzodiazepines, acknowledging the serious risks of abuse, addiction, physical dependence, and withdrawal reactions — sixty years after these drugs came to market. The FDA explicitly acknowledged that protracted withdrawal syndrome persists beyond four to six weeks after initial benzodiazepine withdrawal.

That acknowledgment was meaningful. It was also wildly insufficient.

A boxed warning does not stop the prescribing practices that are injuring people. It does not fund research into treatment. It does not train physicians to recognize BIND. It does not create tapering protocols. It does not hold pharmaceutical manufacturers accountable for the harm their products have caused. And it does not help the millions of people who are already injured and have nowhere to turn.

What the research looks like — and what it doesn't

Prior to the first major BIND survey, the largest clinical study of protracted benzodiazepine withdrawal examined just 50 subjects — and was conducted in 1987. Nearly four decades passed with almost no research into what happens to people after benzo withdrawal. The term BIND was coined in 2023 by the Benzodiazepine Nosology Workgroup — 23 researchers and clinicians — and published in PLOS ONE (Ritvo et al.).

There is currently no standard clinical protocol for treating BIND. No FDA-approved intervention. No established tapering schedule that prevents neurological injury. The FDA itself has acknowledged that "no standard benzodiazepine tapering schedule is suitable for all patients." But rather than funding the research to develop better approaches, the response has been to note the problem and leave physicians and patients to figure it out alone.

The people who are figuring it out are largely the patients themselves — sharing information in online communities, funding their own treatments, reading research papers at 3am because no doctor can help them. This is not acceptable for a public health problem of this scale.

What needs to happen

I am not a policy expert. But I know what I wish had existed when I was injured, and I know what the community of millions of injured people around me needs. Here is what I would ask:

Reclassify benzodiazepines to reflect their actual harm profile. These are Schedule IV substances — in the same category as anabolic steroids. Their dependence liability, withdrawal severity, and potential for long-term neurological injury place them closer to Schedule II or III in terms of the monitoring and prescribing controls they warrant. The current classification has created a false sense of safety that has contributed directly to the overprescribing that is injuring millions of people.

Fund research into BIND treatment. The opioid crisis generated billions in research funding for addiction treatment, overdose reversal, and recovery support. The benzo crisis has generated almost none directed at neurological recovery. We need clinical trials. We need mechanistic research. We need treatment protocols. None of this will happen without dedicated funding.

Mandate physician education. Most physicians prescribing benzodiazepines today have no meaningful training in benzo dependence, BIND, or safe tapering protocols. Many are still prescribing two-week tapers that are known to cause injury. This is not a physician failure — it is a systemic failure to provide education. It needs to be corrected at the level of medical training and continuing education requirements.

Create patient support infrastructure. The opioid crisis created treatment centers, recovery coaches, harm reduction programs, and community support systems with public funding. People with BIND have BenzoBuddies forums and individual coaches like me — people who figured it out for themselves and are now trying to help others. That is not sufficient for a public health crisis of this scale.

Hold pharmaceutical manufacturers accountable. The companies that manufactured and marketed these drugs knew about their dependence potential and downplayed it for decades. The tobacco industry was held accountable. The opioid manufacturers — eventually, partially — were held accountable. The benzodiazepine manufacturers have faced essentially no legal or financial accountability for the harm their products have caused. Class action litigation is one avenue. Regulatory action is another. But the current situation — in which manufacturers profit while patients bear all the consequences — is indefensible.

A personal note

I was prescribed lorazepam — Ativan — after a neurological injury from heat exhaustion, by a doctor who meant well. For sleep. For one month. My doctor tapered me off in two weeks. That taper injured me. I then spent months in progressive neurological decline, alone, largely unable to move, because I had no information about what was happening to me and no clinical support that understood my condition.

I have spent years now reading the research, finding the treatments, building the framework that might have helped me if it had existed. I built a website to share what I know for free, because I cannot justify sitting on information while people are suffering the way I suffered — the way I am still suffering.

But individual people building websites is not a public health response. This problem requires institutional attention, political will, and the kind of sustained commitment that only governments and regulatory bodies can provide.

The opioid epidemic killed people visibly and dramatically. It generated headlines. Benzodiazepine injury kills people too — through suicide, through the medical consequences of long-term neurological dysfunction, through the slow destruction of lives that never recover. It also generates something the opioid crisis didn't generate as much: invisible suffering. People in dark rooms, alone, not sleeping, losing jobs and relationships and years of their lives, told by their doctors that what's happening to them isn't real.

It's real. It's happening at enormous scale. And it will keep happening until someone with the power to stop it decides that it matters enough to act.

I am asking you to decide that.

— Justin Michelson, Pacific Northwest, 2025

A note on current events — and a direct message to Secretary Kennedy

As I publish this, something is happening in Washington that's worth naming directly. On May 4, 2026, HHS Secretary Robert F. Kennedy Jr. announced a major initiative to curb the overprescribing of psychiatric medications. He called it "clear and decisive action." He talked about patient autonomy, informed consent, the need to shift away from medication as the default. He announced new Medicare and Medicaid reimbursement pathways for physicians who help patients taper off psychiatric drugs. He acknowledged that discontinuation is hard and that patients need support.

Secretary Kennedy — you are looking in exactly the right direction. But you are stopping one drug class short.

Your initiative focuses on SSRIs. SSRIs can cause discontinuation syndrome that is real and underacknowledged. But benzodiazepines — Schedule IV controlled substances, still prescribed to 30 million Americans annually — cause neurological injury on a scale that dwarfs what SSRIs produce. They cause physical dependence in weeks. They cause protracted withdrawal that can last years. They cause a condition — BIND — that was only formally named in 2023, that has no standard clinical treatment, and that is currently affecting an estimated 1.8 to 2.75 million new people every year in this country.

You have described SSRIs as "harder to quit than heroin." With respect: benzodiazepines actually are harder to quit than heroin for many people — and the neurological consequences of the injury they cause are far more severe and far less studied than SSRI discontinuation syndrome. If the MAHA agenda is about confronting pharmaceutical harm honestly, benzodiazepines need to be in this conversation. They need to be in it urgently.

The infrastructure you are building — tapering support, physician education, deprescribing guidelines — is exactly what the benzo-injured community needs. We just need you to extend it to us.

Take action — make some noise

If this resonates with you — if you're injured, if someone you love is injured, if you're just angry that this is happening at this scale with this little accountability — here's what you can do right now:

  • Share this post — on X, Reddit, Facebook, wherever you exist online. Tag @SecKennedy and @HHSgov directly. This initiative is live and active — now is the moment.
  • File a MedWatch report — if you were injured by benzodiazepines, report it at fda.gov/safety/medwatch. This is the database that triggered the 2020 boxed warning. Every report counts.
  • Contact HHS directly — hhs.gov/about/contact-us. It goes on record.
  • Contact the Benzodiazepine Information Coalition — benzoinfo.com. They have established channels with FDA and HHS that have already produced results.
  • Share your own story — publicly, if you're able. The 2017 MedWatch reporting drive worked because thousands of people told their stories at the same time. That's how this moves.

Sources cited in this piece:

Mian MN, et al. (2019). Benzodiazepine Use and Misuse Among Adults in the United States. Psychiatric Services. PubMed: 30554562  ·  Tennessee Poison Control Center (2022). FDA Boxed Warning for Benzodiazepines  ·  FDA.gov (2020). FDA Requiring Boxed Warning Updated to Improve Safe Use of Benzodiazepine Drug Class  ·  Benzodiazepine Information Coalition (2020). FDA 2020 Benzodiazepine Boxed Warning  ·  Popa SL, et al. (2023). Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey. PLOS ONE. PMC10309976  ·  Soyka M (2020). Benzodiazepines: Thinking outside the black box. PubMed: 33347636

What BIND
Actually Is

A plain-language guide to the mechanisms — GABA, NMDA, neuroinflammation, and why your nervous system behaves the way it does.

If you’re reading this, you probably already know something is wrong. You might have a name for it — BIND, protracted withdrawal, post-acute withdrawal syndrome — or you might just know that you took a prescribed medication, stopped taking it, and your nervous system has been behaving strangely ever since. Either way, this is for you.

Understanding what’s actually happening doesn’t fix it. But it changes your relationship to it. Mystery amplifies fear. Knowing the mechanism — even an incomplete, uncertain version of it — gives you something to work with instead of just something to endure.

What BIND is

BIND stands for Benzodiazepine-Induced Neurological Dysfunction. It’s the term coined in 2023 by the Benzodiazepine Nosology Workgroup — a group of 23 researchers and clinicians — to describe the neurological symptoms that persist after benzodiazepine use, beyond the acute withdrawal period.

It is not acute withdrawal. Acute withdrawal is the body’s immediate reaction to the sudden absence of a substance it had adapted to — typically lasting days to weeks, and well understood by medicine. BIND is something different: a state of neurological dysregulation that can persist for months or years after complete discontinuation. The mechanisms overlap but they are not the same condition.

It is also not addiction, though the two get conflated constantly. That distinction matters enormously and has its own piece. For now: BIND happens to people who were taking their medication as prescribed, at the recommended dose, for a legitimate reason. It is a pharmacological injury, not a behavioral one.

The GABAergic floor

Benzodiazepines work by amplifying the activity of GABA — the brain’s primary inhibitory neurotransmitter. GABA is essentially the braking system of your nervous system. When a signal fires, GABA is what brings it back to baseline. Calm, rest, sleep, the ability to tolerate sensation without overreacting — all of this depends substantially on functional GABAergic tone.

Benzodiazepines bind to GABA-A receptors and make them respond more strongly to GABA than they normally would. This is why they work so well for anxiety and insomnia in the short term. The problem is what happens next.

When GABA-A receptors are chronically over-stimulated, they compensate. They downregulate — reducing both their number and their sensitivity, to maintain some equilibrium in the face of the drug’s amplifying effect. This is physical dependence. It happens to essentially everyone who takes benzodiazepines regularly for more than a few weeks. It is not a character flaw. It is what GABA receptors do.

When the drug is removed, the downregulated receptors are suddenly operating without the amplification they had adapted to. The inhibitory floor collapses. Everything that GABA was keeping in check — arousal, sensory reactivity, anxiety, pain signaling, sleep architecture — comes flooding back, often much louder than before. This is why withdrawal can be so severe and why rapid tapers are so dangerous.

In BIND, this downregulation doesn’t simply reverse on a short timetable. For reasons that are still being researched, the GABAergic system in some people takes months or years to recalibrate. Without an adequate inhibitory floor, everything else goes wrong.

NMDA upregulation

The nervous system maintains balance through a push-pull between inhibition (GABA) and excitation (primarily glutamate, acting through NMDA and AMPA receptors). When GABA is suppressed, the excitatory side doesn’t stay static — it upregulates to fill the vacuum.

Chronic NMDA receptor upregulation is one of the central drivers of BIND symptomatology. It drives excitotoxicity — a state where neurons are being overstimulated to a degree that is directly damaging. It drives the hypersensitivity to sound, light, touch, and movement that many BIND patients describe. It drives the cognitive dysfunction, the inability to filter, the sensation of being perpetually overwhelmed by ordinary input. And it perpetuates neuroinflammation, because chronically activated neurons trigger immune responses.

GABA collapse and NMDA upregulation are mutually reinforcing. Each makes the other worse. This is why BIND can feel like it compounds over time rather than simply resolving — and why simply waiting for GABA receptors to recover, while ignoring NMDA overdrive, misses half the picture.

Neuroinflammation

The third major driver is neuroinflammation — chronic activation of the brain’s immune cells (microglia) and the inflammatory cascades they trigger. Neuroinflammation in BIND is driven by multiple overlapping mechanisms: NMDA excitotoxicity, blood-brain barrier dysfunction, mast cell activation (a specific immune pathway that is dysregulated in a significant subset of BIND patients), and sometimes prior infections or toxic exposures that interact with the benzo injury.

Neuroinflammation produces its own symptoms: cognitive fog, fatigue that doesn’t respond to rest, a global dampening of function. It also impairs the neuroplasticity and neurotrophic support that the brain needs to heal. You cannot rebuild what you are simultaneously inflaming.

Autonomic dysregulation

The autonomic nervous system — the involuntary nervous system that regulates heart rate, blood pressure, breathing, digestion, and the threat response — is profoundly disrupted in BIND. This is partly a consequence of the GABAergic and glutamatergic imbalances above, and partly a result of direct effects on brainstem regulatory centers.

The result is a nervous system that has lost its ability to modulate its own threat response. Stimuli that should be neutral — a sound, a smell, a change in light — trigger sympathetic activation that a healthy nervous system would filter. The body is stuck in a state of low-grade emergency that it cannot exit. This is not anxiety in the psychological sense. It is a hardware problem.

Who gets it and why

Not everyone who takes benzodiazepines develops BIND. The risk factors are not fully understood, which is one of the most frustrating aspects of the condition. What we know: duration of use matters, dose matters, speed of taper matters, and individual genetic factors (including CYP enzyme variants and GABA receptor genetics) appear to matter significantly.

What is also clear is that BIND is not rare. Estimates suggest 10–25% of long-term benzo users develop protracted symptoms. Given that 30 million Americans are prescribed benzodiazepines annually, the potential scale of this problem is enormous — and almost entirely unaddressed by mainstream medicine.

What this means for recovery

Understanding the mechanisms suggests the directions for recovery: rebuilding GABAergic tone, reducing NMDA overactivation, lowering neuroinflammation, and stabilizing the autonomic nervous system. These four pillars are what the framework on this site is built around.

None of this is certain. The research is genuinely thin. Individual variation is enormous. What works for one person does nothing for another, and what helps at one point in recovery can set you back at another. This is a condition that is still being figured out in real time — by researchers, by clinicians, and most importantly by the people living it.

What I can say with confidence is that the mechanisms are real, the suffering is real, and the people going through it deserve better than “wait and see.” That’s why this site exists.

Why Nature Isn’t Just
Good Advice

It’s nervous system medicine. And for a BIND nervous system, the distinction matters.

When people suggest nature to someone who is suffering — go for a walk, get outside, breathe some fresh air — it sounds like the soft advice you give when you don’t have anything real to offer. Like suggesting a cup of tea for a broken leg.

I run a native plant nursery outside Eugene. I’ve spent years in the forests and meadows and river corridors of the Pacific Northwest. The natural world was the center of my spiritual life long before formal meditation entered it. So when I tell you that sitting outside under a Douglas fir was one of the more genuinely therapeutic things I did during my BIND recovery, I want to be clear: I’m not saying it because it sounds nice. I’m saying it because something was measurably happening in my body, and I noticed it the same way I noticed everything else I was trying — by paying attention.

What phytoncides actually do

Trees emit volatile organic compounds called phytoncides — primarily terpenes — as part of their defense and communication systems. When you breathe forest air, you are breathing these compounds. They are not metaphorical. They are chemistry.

Research on forest bathing (shinrin-yoku) has documented consistent, measurable effects from phytoncide exposure: reduced cortisol, decreased blood pressure, lower heart rate, increased NK cell activity, reduced sympathetic nervous system output. [PMC 2023] These are not placebo effects or relaxation effects that would occur anywhere quiet — studies comparing forest environments to urban environments with equivalent noise levels still show the forest-specific benefits.

For a BIND nervous system, this matters specifically. Reduced cortisol means less HPA-axis activation, less adrenergic drive, less sympathetic tone — all of which directly supports recovery from the autonomic dysregulation that is central to BIND. NK cell activation suggests immune modulation, which may be relevant for the neuroinflammatory dimension. None of this is a cure. But none of it is nothing either.

Negative ions and the amygdala

Natural environments — particularly near water, after rain, in forests — have higher concentrations of negative ions than urban or indoor environments. The evidence on negative ions is more contested than the phytoncide literature, but some research suggests effects on serotonin metabolism and reduced amygdala reactivity.

What I can say from experience: there is something qualitatively different about being near a river or in old growth versus being inside a building. I could feel it. The nervous system is not the same in those two places — not in a poetic sense, in a measurable physiological sense. Whether that’s negative ions, reduced electromagnetic noise, phytoncides, visual complexity, or the accumulated effect of evolutionary history spent in exactly this kind of environment — I don’t know. Probably all of it. I stopped needing to understand the mechanism before I used it as a tool.

The visual complexity effect

Natural environments have what researchers call high fractal dimension — complex, self-similar patterns that repeat across scales, like a coastline or a forest canopy. The human visual system appears specifically calibrated to process these patterns. Looking at natural fractal geometry reduces stress responses measurably, in ways that looking at geometric patterns or urban environments does not.

There’s a hypothesis that this reflects something deep about human evolutionary history — that the nervous system evolved in natural environments and is, in some sense, optimized to be in them. I find this plausible. The BIND nervous system is one that has lost its ability to regulate itself. An environment that produces reliable, passive downregulation just by being looked at seems like an obvious thing to use.

How I used it practically

I want to be concrete, because “spend time in nature” is not a protocol.

During the worst of my recovery, I couldn’t do much. Even short walks were difficult. What I could do was sit. I would go outside and sit near trees — in my yard, at the edge of a field, sometimes just in a doorway facing the garden — and do nothing except be there. Watch a spider. Listen to wind in the canopy. Let my eyes soften on something green. No phone. No agenda. Just presence in a natural environment, which is something the nervous system seems to know what to do with even when it’s forgotten how to do almost everything else.

Even 15 to 20 minutes of this produced a noticeable shift in my baseline activation. Not dramatic. Not curative. But real and repeatable. I started treating it the same way I treated other interventions — as something that had a measurable effect and therefore warranted regular use.

As I got better, longer time outdoors became available. Sitting became walking. Walking became foraging, tracking, spending whole mornings in old growth. The nervous system effect scaled with the duration and depth of immersion. But even the minimal version — 15 minutes outside, actually attending to what was around me — was worth doing every single day.

Why this matters alongside everything else

BIND recovery is substantially a process of rebuilding the nervous system’s capacity for regulation. Most of the pharmaceutical and peptide interventions I’ve written about work at the level of receptor function, inflammatory pathways, or neurotransmitter systems. Nature works at a different level — the level of the whole organism in its environment. It produces downregulation not by manipulating a receptor but by providing the conditions the nervous system was built to inhabit.

These are not competing approaches. They work together. The interventions give the nervous system the biochemical substrate it needs to recover. Nature gives it a context in which recovery is possible — a reminder, at the cellular level, of what regulated actually feels like. Both matter.

Zero cost. Zero risk. Zero tolerance development. No prescription, no provider, no shipping time. A doorway and something living on the other side of it. That’s a more favorable profile than almost anything else on the What I’ve Tried page — and it’s been here the whole time.

Buddhist Practice
in BIND Recovery

Impermanence as medicine. How the oldest teachings on suffering became survival tools in the middle of a neurological crisis.

On my worst nights, when the autonomic surges ran all night and the intrusive thoughts were loudest and sleep felt permanently out of reach, I would lie in the dark and try to find one breath that wasn’t a battlefield. Sometimes I could. Sometimes I couldn’t. Either way, the trying mattered more than I understood at the time.

I was a meditation teacher before I got sick. I want to be clear about that because it changes what I’m saying here. I’m not someone who found Buddhism after getting injured and is now attributing my recovery to it in the way people sometimes attribute recovery to whatever they were doing at the time. The practice was already the center of my life. And when everything fell apart, I found out what it was actually made of.

What the practice couldn’t do

I want to start here, with what didn’t happen — because a lot of writing about meditation and illness tends to oversell the medicine.

Meditation did not fix my GABA receptors. It did not reduce my neuroinflammation in any direct or measurable way. It did not stop the autonomic surges, the trigeminal pain, the sensory hypersensitivity. There were days — many of them — when sitting was impossible, when the effort to attend to my own experience was more activating than it was calming, when the practice felt inaccessible in a body that had become a hostile environment.

If you’re in the acute phase of BIND and someone tells you meditation will help, and then it doesn’t, please know that the failure is not yours. A seriously dysregulated nervous system sometimes cannot do formal meditation. That’s not a spiritual problem. It’s a physiological one.

What it could do

What practice could do — even in the worst of it, even when formal sitting was impossible — was change my relationship to what was happening.

This sounds small. It isn’t. When you are suffering enormously, the relationship between you and the suffering is not incidental. It is a substantial part of the total experience. Fear of the symptoms, catastrophizing about their permanence, the desperate search for the thing that will make it stop — all of this is suffering layered on top of suffering. And all of it, paradoxically, maintains the very neurological activation you’re trying to escape.

The central teaching of Vipassana — the form I practice, rooted in Theravada Buddhism — is that all phenomena are impermanent. Not as consolation. Not as poetry. As direct, experiential observation of what is actually happening in this moment. This sensation, this fear, this surge of activation — it is not permanent. It is already changing, even as you observe it. The practice is to see this clearly, repeatedly, until it becomes more than a thought. Until it becomes a way of inhabiting experience that can hold even the worst of what BIND produces.

The neurological case for impermanence

There is actually a neuroscience argument for why this works, which I find interesting even though it wasn’t what made it useful to me.

The threat response — the sympathetic activation, the cortisol spike, the amygdala firing — is not triggered only by present danger. It is triggered by anticipated danger, by the projection of a terrible present into an imagined permanent future. When you are in pain and your nervous system concludes that you will always be in pain, the threat response is continuous. There is no safety signal because safety is defined as the absence of the thing that is currently happening.

Working with impermanence doesn’t make the pain go away. But it changes the threat calculation. This moment of pain is real. The permanent future of pain is a story. And the nervous system responds differently to a present difficulty than to an existential catastrophe.

Compassion as biological medicine

The other practice that became genuinely therapeutic was metta — loving-kindness — which I had always found somewhat formal and a little difficult to believe in. BIND changed that.

When you are suffering at the level BIND produces, the natural response is a kind of contraction — an understandable narrowing of attention onto the pain, an isolation, a sense that the suffering is deeply personal and uniquely terrible. This contraction is itself activating. It is the nervous system turning inward under threat, which produces more threat response, which produces more contraction.

What metta practice does — even done badly, even done skeptically, even offered in a brief, exhausted fragment from a dark room — is interrupt that contraction. To genuinely wish another person well, even for thirty seconds, is to step outside the pain narrative. Something in the nervous system softens. I can’t fully account for the mechanism, but I noticed it working, repeatedly, and I stopped needing it to make theoretical sense before I used it.

Practical notes

A few things I learned about using practice during neurological illness:

Short is better than long. A five-minute sit with genuine attention is more useful than a twenty-minute sit that is largely aversion to the experience. In BIND, endurance is not a virtue. Sensitivity is.

Body scanning can be activating. For a sensitized nervous system, scanning through areas of pain or dysfunction can amplify rather than soothe. If this is happening, shift to something less body-focused — breath at the nostrils, sound, or metta.

Informal practice matters more than formal practice. The question “what is my relationship to this moment?” doesn’t require a cushion. It can be asked anywhere, at any moment, in any level of symptom. During the times I couldn’t sit at all, this question was still available.

The practice is not to feel better. It is to relate to the experience of not feeling better differently. This is a distinction that sounds semantic and isn’t.

What I would say to someone just starting

If you have no meditation background and are in the middle of BIND, I would not tell you to start a formal practice right now. I would tell you to find one moment in your day when you can notice, without trying to change it, that the moment you are in is impermanent. That the thing you are experiencing — however terrible — is not solid, not permanent, not the full truth of what is possible for you. Let that be enough for now.

The nervous system recovers. I know this from my own experience, and from the research, and from everyone I’ve talked to who has come through it. The recovery is slower and stranger than you want it to be. There are windows of better and crashes back down, and a long middle period where the ground shifts unpredictably beneath you.

In that slowness, the relationship to experience matters enormously. Not the symptoms themselves — you can’t always change those — but your relationship to them. Whether this moment of suffering is the whole truth of what is possible, or just one wave in a longer pattern that is already, beneath the surface, returning toward shore. Practice gives you somewhere to put that question. And that, it turns out, is not nothing.